Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 537
Encontrada(s) 6 página(s)

Biblos-e Archivo. Repositorio Institucional de la UAM
Publicación Artículo científico (JournalArticle)

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector

  • Aad, G.
  • Barreiro Alonso, Fernando
  • Batlamous, S.
  • Collado Soto, P.
  • Cueto, A.
  • Peso Malagón, José del
  • Glasman Kuguel, Claudia Beatriz
  • Pascual Dominguez, L.
  • Principe Martin, M. A.
  • Terrón Cuadrado, Juan
  • The Atlas Collaboration
Artículo escrito por un elevado número de autores. Solo se referencia el que aparece en primer lugar, el nombre del grupo de colaboración, si hubiere, y los autores pertenecientes a la UAM, A search for the dimuon decay of the Higgs boson is presented based on (Formula presented) collision data recorded by ATLAS during Run 3 of the Large Hadron Collider, corresponding to an integrated luminosity of (Formula presented) at (Formula presented). To enhance the sensitivity, the results are combined with those from Run 2. An excess of events over the background is observed with a significance of (Formula presented) ((Formula presented) expected). The best-fit signal strength is (Formula presented). This result provides evidence for the (Formula presented) decay with ATLAS data and offers a direct probe of the Higgs-boson Yukawa coupling to second-generation fermions, We thank CERN for the very successful operation of the LHC and its injectors, as well as the support staff at CERN and at our institutions worldwide without whom ATLAS could not be operated efficiently. The crucial computing support from all WLCG partners is acknowledged gratefully, in particular from CERN, the ATLAS Tier-1 facilities at TRIUMF/SFU (Canada), NDGF (Denmark, Norway, Sweden), CC-IN2P3 (France), KIT/ GridKA (Germany), INFN-CNAF (Italy), NL-T1 (Netherlands), PIC (Spain), RAL (UK) and BNL (USA), the Tier-2 facilities worldwide and large non-WLCG resource providers. Major contributors of computing resources are listed in Ref. [53].We gratefully acknowledge the support of ANPCyT, Argentina; YerPhI, Armenia; ARC, Australia; BMWFW and FWF, Austria; ANAS, Azerbaijan; CNPq and FAPESP, Brazil; NSERC, NRC and CFI, Canada; CERN; ANID, Chile; CAS, MOST and NSFC, China; Minciencias, Colombia; MEYS CR, Czech Republic; DNRF and DNSRC, Denmark; IN2P3-CNRS and CEA-DRF/IRFU, France; SRNSFG, Georgia; BMFTR, HGF and MPG, Germany; GSRI, Greece; RGC and Hong Kong SAR, China; ICHEP and Academy of Sciences and Humanities, Israel; INFN, Italy; MEXT and JSPS, Japan; CNRST, Morocco; NWO, Netherlands; RCN, Norway; MNiSW, Poland; FCT, Portugal; MNE/IFA, Romania; MSTDI, Serbia; MSSR, Slovakia; ARIS and MVZI, Slovenia; DSI/NRF, South Africa; MICIU/AEI, Spain; SRC and Wallenberg Foundation, Sweden; SERI, SNSF and Cantons of Bern and Geneva, Switzerland; NSTC, Taipei; TENMAK, Türkiye; STFC/UKRI, United Kingdom; DOE and NSF, USA. Individual groups and members have received support from BCKDF, CANARIE, CRC and DRAC, Canada; CERN-CZ, FORTE and PRIMUS, Czech Republic; COST, ERC, ERDF, Horizon 2020, ICSC-NextGenerationEU and Marie Skłodowska-Curie Actions, European Union; Investissements d’Avenir Labex, Investissements d’Avenir Idex and ANR, France; DFG and AvH Foundation, Germany; Herakleitos, Thales and Aristeia programmes co-financed by EU-ESF and the Greek NSRF, Greece; BSF-NSF and MINERVA, Israel; NCN and NAWA, Poland; La Caixa Banking Foundation, CERCA Programme Generalitat de Catalunya and PROMETEO and GenT Programmes Generalitat Valenciana, Spain; Göran Gustafssons Stiftelse, Sweden; The Royal Society and Leverhulme Trust, United Kingdom. In addition, individual members wish to acknowledge support from CERN: European Organization for Nuclear Research (CERN DOCT); Chile: Agencia Nacional de Investigación y Desarrollo (FONDECYT 1230812, FONDECYT 1240864, Fondecyt 3240661); China: ChineseMinistry of Science and Technology (MOST-2023YFA1605700, MOST- 2023YFA1609300), National Natural Science Foundation of China (NSFC—12175119, NSFC 12275265); Czech Republic: Czech Science Foundation (GACR—24- 11373S), Ministry of Education Youth and Sports (ERCCZ- LL2327, FORTE CZ.02.01.01/00/22_008/0004632), PRIMUS Research Programme (PRIMUS/21/SCI/017); EU: H2020 European Research Council (ERC— 101002463); European Union: European Research Council (BARD No. 101116429, ERC—948254, ERC 101089007), European Regional Development Fund (SMASH COFUND 101081355, SLO ERDF), Horizon 2020 Framework Programme (MUCCA—CHIST-ERA-19-XAI-00), European Union, Future Artificial Intelligence Research (FAIR-NextGenerationEU PE00000013), Italian Center for High Performance Computing, Big Data and Quantum Computing (ICSC, NextGenerationEU); France: Agence Nationale de la Recherche (ANR-21-CE31-0022, ANR- 22-EDIR-0002); Germany: Baden-Württemberg Stiftung (BW Stiftung-Postdoc Eliteprogramme), Deutsche Forschungsgemeinschaft (DFG—469666862, DFG—CR 312/5-2); China: Research Grants Council (GRF); Italy: Istituto Nazionale di Fisica Nucleare (ICSC, NextGenerationEU), Ministero dell’Universit`a e della Ricerca (NextGenEU 153D23001490006 M4C2.1.1, NextGenEU I53D23000820006 M4C2.1.1, NextGenEU I53D23001490006 M4C2.1.1, SOE2024_0000023); Japan: Japan Society for the Promotion of Science (JSPSKAKENHI JP22H01227, JSPS KAKENHI JP22H04944, JSPS KAKENHI JP22KK0227, JSPS KAKENHI JP24K23939, JSPS KAKENHI JP24KK0251, JSPS KAKENHI JP25H00650, JSPS KAKENHI JP25H01291, JSPS KAKENHI JP25K01023); Norway: Research Council of Norway (RCN-314472); Poland: Ministry of Science and Higher Education (IDUB AGH, POB8, D4 no 9722), Polish National Science Centre (NCN 2021/42/E/ST2/00350, NCN OPUS 2023/51/B/ST2/02507, NCN OPUS nr 2022/47/B/ ST2/03059,NCNUMO-2019/34/E/ST2/00393,UMO-2022/ 47/O/ST2/00148, UMO-2023/49/B/ST2/04085, UMO- 2023/51/B/ST2/00920, UMO-2024/53/N/ST2/00869); Portugal: Foundation for Science and Technology (FCT); Spain: Ministry of Science and Innovation (MCIN and NextGenEU PCI2022-135018-2, MICIN & FEDER PID2021-125273NB, RYC2019-028510-I, RYC2020- 030254-I, RYC2021-031273-I, RYC2022-038164-I); Sweden: Carl Trygger Foundation (Carl Trygger Foundation CTS 22∶2312), Swedish Research Council (Swedish Research Council 2023-04654, VR 2021-03651, VR 2022-03845, VR 2022-04683, VR 2023-03403, VR 2024-05451), Knut and Alice Wallenberg Foundation (KAW 2018.0458, KAW 2022.0358, KAW 2023.0366); Switzerland: Swiss National Science Foundation (SNSF— PCEFP2_194658); United Kingdom: Royal Society (NIFR1- 231091); USA: U.S. Department of Energy (ECA DEAC02- 76SF00515), Neubauer Family Foundation
Biblos-e Archivo. Repositorio Institucional de la UAM
Publicación Artículo científico (JournalArticle)

Constraining off-shell Higgs boson production and the Higgs boson total width using WW → ℓνℓν final states with the ATLAS detector

  • Aad, G.
  • The Atlas Collaboration
  • Barreiro Alonso, Fernando
  • Batlamous, S.
  • Collado Soto, P.
  • Cueto, A.
  • Peso Malagón, José del
  • Glasman Kuguel, Claudia Beatriz
  • Pascual Dominguez, L.
  • Principe Martin, M.A.
  • Terrón Cuadrado, Juan
Artículo escrito por un elevado número de autores. Solo se referencia el que aparece en primer lugar, el nombre del grupo de colaboración, si hubiere, y los autores pertenecientes a la UAM, A measurement of off-shell Higgs boson production is performed in the 𝐻∗ → 𝑊𝑊 channel. The measurement uses a proton–proton collision dataset with an integrated luminosity of 140 fb−1 collected at a centre-of-mass energy of 13 TeV by the ATLAS detector at the Large Hadron Collider. Final states in which both 𝑊 bosons decay leptonically are targeted, and events are categorised based on the flavour of the final-state leptons, the jet multiplicity, and the output of neural network-based classifiers. The data are found to be compatible with the Standard Model expectation. An observed (expected) upper bound on the 95% symmetric confidence level interval is set on the rate of off-shell Higgs boson production at a value of 3.4 (4.4) times the Standard Model prediction. These results are combined with the results from the measurement of on-shell Higgs boson production in the same final states to obtain an observed (expected) upper bound at 95% confidence level on the Higgs boson total width of 13.1 (17.3) MeV, We thank CERN for the very successful operation of the LHC and its injectors, as well as the support staff at CERN and at our institutions worldwide without whom ATLAS could not be operated efficiently. The crucial computing support from all WLCG partners is acknowl-edged gratefully, in particular from CERN, the ATLAS Tier-1 facilities at TRIUMF/SFU (Canada), NDGF (Denmark, Norway, Sweden), CC-IN2P3 (France), KIT/GridKA (Germany), INFN-CNAF (Italy), NL-T1 (Nether-lands), PIC (Spain), RAL (UK) and BNL (USA), the Tier-2 facilities world-wide and large non-WLCG resource providers. Major contributors of computing resources are listed in Ref. [110]. We gratefully acknowledge the support of ANPCyT, Argentina; YerPhI, Armenia; ARC, Australia; BMWFW and FWF, Austria; ANAS, Azerbaijan; CNPq and FAPESP, Brazil; NSERC, NRC and CFI, Canada; CERN; ANID, Chile; CAS, MOST and NSFC, China; Minciencias, Colombia; MEYS CR, Czech Republic; DNRF and DNSRC, Denmark; IN2P3-CNRS and CEA-DRF/IRFU, France; SRNSFG, Georgia; BMFTR, HGF and MPG, Germany; GSRI, Greece; RGC and Hong Kong SAR, China; ICHEP and Academy of Sciences and Humanities, Israel; INFN, Italy; MEXT and JSPS, Japan; CNRST, Morocco; NWO, Netherlands; RCN, Norway; MNiSW, Poland; FCT, Portugal; MNE/IFA, Romania; MSTDI, Serbia; MSSR, Slovakia; ARIS and MVZI, Slovenia; DSI/NRF, South Africa; MICIU/AEI, Spain; SRC and Wallenberg Foundation, Sweden; SERI, SNSF and Cantons of Bern and Geneva, Switzerland; NSTC, Taipei; TENMAK, Türkiye; STFC/UKRI, United Kingdom; DOE and NSF, United States of America. Individual groups and members have received support from BCKDF, CANARIE, CRC and DRAC, Canada; CERN-CZ, FORTE and PRIMUS, Czech Republic; COST, ERC, ERDF, Horizon 2020, ICSC-NextGenerationEU and Marie Skłodowska-Curie Actions, European Union; Investissements d’Avenir Labex, Investissements d’Avenir Idex and ANR, France; DFG and AvH Foundation, Germany; Herakleitos, Thales and Aristeia programmes co-financed by EU-ESF and the Greek NSRF, Greece; BSF-NSF and MINERVA, Israel; NCN and NAWA, Poland; La Caixa Banking Foundation, CERCA Programme Generalitat de Catalunya and PROMETEO and GenT Programmes Generalitat Valen-ciana, Spain; Göran Gustafssons Stiftelse, Sweden; The Royal Society and Leverhulme Trust, United Kingdom. In addition, individual members wish to acknowledge support from Armenia: Yerevan Physics Institute (FAPERJ); CERN: European Organization for Nuclear Research (CERN DOCT); Chile: Agencia Nacional de Investigación y Desarrollo (FONDECYT 1230812, FONDE-CYT 1240864); China: Chinese Ministry of Science and Technology (MOST-2023YFA1605700, MOST-2023YFA1609300), National Natural Science Foundation of China (NSFC - 12175119, NSFC 12275265); Czech Republic: Czech Science Foundation (GACR - 24-11373S), Ministry of Education Youth and Sports (ERC-CZ-LL2327, FORTE CZ.02.01.01/00/22_008/0004632), PRIMUS Research Programme (PRIMUS/21/SCI/017); EU: H2020 European Research Council (ERC - 101002463); European Union: European Research Council (BARD No. 101116429, ERC - 948254, ERC 101089007), European Regional Devel-opment Fund (SMASH COFUND 101081355, SLO ERDF), Horizon 2020 Framework Programme (MUCCA - CHIST-ERA-19-XAI-00), European Union, Future Artificial Intelligence Research (FAIR-NextGenerationEU PE00000013), Horizon 2020 (EuroHPC - EHPC-DEV-2024D11-051), Italian Center for High Performance Computing, Big Data and Quantum Computing (ICSC, NextGenerationEU); France: Agence Nationale de la Recherche (ANR-21-CE31-0022, ANR-22-EDIR-0002); Germany: Baden-Württemberg Stiftung (BW Stiftung-Postdoc Eliteprogramme),Deutsche Forschungsgemeinschaft (DFG - 469666862, DFG - CR 312/5-2); China: Research Grants Council (GRF); Italy: Istituto Nazionale di Fisica Nucleare (ICSC, NextGenerationEU), Ministero dell’Università e della Ricerca (NextGenEU 153D23001490006 M4C2.1.1, NextGenEU I53D23000820006 M4C2.1.1, NextGenEU I53D23001490006 M4C2.1.1); Japan: Japan Society for the Promotion of Science (JSPS KAKENHI JP22H01227, JSPS KAKENHI JP22H04944, JSPS KAKENHI JP22KK0227, JSPS KAKENHI JP23KK0245, JSPS KAKENHI JP24K23939); Norway: Research Council of Norway (RCN-314472); Poland: Ministry of Science and Higher Education (IDUB AGH, POB8, D4 no 9722), Polish National Science Centre (NCN 2021/42/E/ST2/00350, NCN OPUS 2023/51/B/ST2/02507, NCN OPUS nr 2022/47/B/ST2/03059, NCN UMO-2019/34/E/ST2/00393, UMO-2022/47/O/ST2/00148, UMO-2023/49/B/ST2/04085, UMO-2023/51/B/ST2/00920, UMO-2024/53/N/ST2/00869); Portugal: Foundation for Science and Technology (FCT); Spain: Generalitat Va-lenciana (Artemisa, FEDER, IDIFEDER/2018/048), Ministry of Science and Innovation (MCIN & NextGenEU PCI2022-135018-2, MICIN & FEDER PID2021-125273NB, RYC2019-028510-I, RYC2020-030254-I, RYC2021-031273-I, RYC2022-038164-I); Sweden: Carl Trygger Foun-dation (Carl Trygger Foundation CTS 22:2312), Swedish Research Council (Swedish Research Council 2023-04654, VR 2021-03651, VR 2022-03845, VR 2022-04683, VR 2023-03403, VR 2024-05451), Knut and Alice Wallenberg Foundation (KAW 2018.0458, KAW 2022.0358, KAW 2023.0366); Switzerland: Swiss National Science Foundation (SNSF - PCEFP2_194658); United Kingdom: Leverhulme Trust (Leverhulme Trust RPG-2020-004), Royal Society (NIF-R1-231091); United States of America: U.S. Department of Energy (ECA DE-AC02-76SF00515), Neubauer Family Foundation
Docta Complutense
Publicación Artículo científico (JournalArticle)

Prospects for γ-ray observations of the Perseus galaxy cluster with the Cherenkov Telescope Array

  • Alvarez-Crespo, N.
  • Barrio Uña, Juan Abel
  • Contreras González, José Luis
  • Láinez, M.
  • López Moya, Marcos
  • Martinez, O.
  • Mas-Aguilar, A.
  • Miener, Tjark
  • Miranda, J.M.
  • Morcuende Parrilla, Daniel
  • Nieto Castaño, Daniel
  • Rosado Vélez, Jaime
  • Sinha, Atreyee
  • Tejedor Álvarez, Luis Ángel
  • Zamanillo, V.M.
Galaxy clusters are expected to be both dark matter (DM) reservoirs and storage rooms for the cosmic-ray protons (CRp) that accumulate along the cluster’s formation history. Accordingly, they are excellent targets to search for signals of DM annihilation and decay at γ-ray energies and are predicted to be sources of large-scale γ-ray emission due to hadronic interactions in the intracluster medium (ICM). In this paper, we estimate the sensitivity of the Cherenkov Telescope Array (CTA) to detect diffuse γ-ray emission from the Perseus galaxy cluster. We first perform a detailed spatial and spectral modelling of the expected signal for both the DM and the CRp components. For each case, we compute the expected CTA sensitivity accounting for the CTA instrument response functions. The CTA observing strategy of the Perseus cluster is also discussed. In the absence of a diffuse signal (non-detection), CTA should constrain the CRp to thermal energy ratio X500 within the characteristic radius R500 down to about X500 < 3 × 10−3, for a spatial CRp distribution that follows the thermal gas and a CRp spectral index αCRp = 2.3. Under the optimistic assumption of a pure hadronic origin of the Perseus radio mini-halo and depending on the assumed magnetic field profile, CTA should measure αCRp down to about ∆αCRp ≃ 0.1 and the CRp spatial distribution with 10% precision, respectively. Regarding DM, CTA should improve the current ground-based γ-ray DM limits from clusters observations on the velocity-averaged annihilation cross-section by a factor of up to ∼ 5, depending on the modelling of DM halo substructure. In the case of decay of DM particles, CTA will explore a new region of the parameter space, reaching models with τχ > 1027 s for DM masses above 1 TeV. These constraints will provide unprecedented sensitivity to the physics of both CRp acceleration and transport at cluster scale and to TeV DM particle models, especially in the decay scenario.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Assessing the energy trap of industrial agriculture in North America and Europe, 82 balances from 1830 to 2012

  • Tello, Enric|||0000-0002-4970-1524
  • Sacristán, Vera|||0000-0003-0203-256X
  • Olarieta, José R.
  • Cattaneo, Claudio|||0000-0001-7049-9298
  • Marull, Joan|||0000-0002-7793-4165
  • Pons, Manel
  • Gingrich, Simone|||0000-0001-7891-8688
  • Krausmann, Fridolin
  • Galán, Elena|||0000-0001-6809-737X
  • Marco, Inés
  • Padro i Caminal, Roc|||0000-0001-7880-5026
  • Guzmán Casado, Gloria Isabel|||0000-0003-1165-7182
  • González de Molina, Manuel|||0000-0002-0253-6971
  • Cunfer, Geoff
  • MacFadyen, Joshua
  • Fraňková, Eva
  • Aguilera Fernández, Eduardo
  • Infante Amate, Juan|||0000-0003-1446-7181
  • Urrego-Mesa, Alexander
  • Soto, David
  • Parcerisas, Lluis
  • Dupras, Jérôme|||0000-0001-5422-6345
  • Díez-Sanjuán, Lucía
  • Caravaca, Jonathan
  • Gómez, Laura
  • Fullana, Onofre
  • Murray, Ivan
  • Jover, Gabriel
  • Cussó i Segura, Xavier|||0000-0001-9274-5031
  • Garrabou, Ramon
Early energy analyses of agriculture revealed that behind higher labor and land productivity of industrial farming, there was a decrease in energy returns on the energy invested (EROI), in comparison to more traditional organic agricultural systems. Studies on recent trends show that efficiency gains in production and use of inputs have again somewhat improved energy returns. However, most of these agricultural energy studies have focused only on external inputs at the crop level, concealing the important role of internal biomass flows that livestock and forestry recirculate within agroecosystems. Here, we synthesize the results of 82 farm systems in North America and Europe from 1830 to 2012 that for the first time show the changing energy profiles of agroecosystems, including livestock and forestry, with a multi-EROI approach that accounts for the energy returns on external inputs, on internal biomass reuses, and on all inputs invested. With this historical circular bioeconomic approach, we found a general trend towards much lower external returns, little or no increases in internal returns, and almost no improvement in total returns. This "energy trap" was driven by shifts towards a growing dependence of crop production on fossil-fueled external inputs, much more intensive livestock production based on feed grains, less forestry, and a structural disintegration of agroecosystem components by increasingly linear industrial farm managements. We conclude that overcoming the energy trap requires nature-based solutions to reduce current dependence on fossil-fueled external industrial inputs and increase the circularity and complexity of agroecosystems to provide healthier diets with less animal products.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

From curing to caring, exploring social care needs after the onset of chronic conditions among European older adults (50+)

  • Calderón Jaramillo, Mariana|||0000-0002-2722-6590
  • Rentería, Elisenda|||0000-0002-7072-8465
  • Spijker, Jeroen|||0000-0002-3957-9553
Background and Objectives: Population aging affects health and social care needs. Although its effects on healthcare needs have been widely discussed, less has been said about its implications on social care needs, even though the consequences of living with chronic conditions are related to functional decline, disability, dependency, and mobility limitation. This study aims to identify trajectories of healthcare and social care needs after the onset of chronic conditions, as well as to explore through cross-country comparisons how demographic, socioeconomic, living arrangements, and health-related dimensions explain individuals' trajectories. Research Design and Methods: Using data from the Survey of Health, Ageing and Retirement in Europe, we analyzed trajectories of 16,718 individuals aged 50 and above from 10 European countries through sequence analysis. Multinomial regression models were fitted to understand the factors that explained these trajectories. Results: This study identified four trajectories after the onset of chronic conditions: (a) "Persistent multimorbidity and social care needs," (b) "Persistent multimorbidity without social care needs," (c) "One chronic condition and social care needs," and (d) "One chronic condition without social care needs and some recoveries." The models present divergences in individuals' characteristics, including demographic and socioeconomic aspects, as well as differences by country, related to each trajectory. Discussion and Implications: By acknowledging trajectories within health and social care needs, we showed the challenges posed by aging processes, which require tailored-made and person-centered services oriented towards preventing and postponing the onset of chronic conditions as well as dealing with their consequences on individuals' daily lives.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Beyond conservative gender roles, exploring the division of paid and unpaid labour among Italian same-sex couples

  • Vitali, Agnese|||0000-0003-0029-9447
  • Geremia, Gioia|||0009-0002-2568-3330
This contribution explores the division of paid and unpaid labour among same-sex couples in Italy relying on primary data collected via an online survey. The (non-probabilistic) sample consists of 190 respondents, mainly women (n = 138), in a co-residing same-sex couple at the survey date. Results from descriptive statistics reveal a general pattern of equal division of both paid and unpaid labour among the majority of couples in our sample-a result which aligns with previous research based on different countries. Same-sex partners in our sample tend to share domestic and childcare chores equally, even when paid labour is not equally shared. This result contrasts markedly with the gender division found among different-sex partners in Italy from existing empirical studies, especially among parents. Finally, we find that in those same-sex couples where the division of childcare is unbalanced, care tasks tend to be skewed towards the respondent irrespective of their relationship to the child, unlike prior international studies suggesting a higher involvement in care tasks for the birth or biological parent.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Migrating alone or with family? mental health among internal and US return migrants in Mexico

  • Odasso, Margherita|||0009-0000-3447-8836
Between 2010 and 2015, more than one million Mexican migrants returned to Mexico from the United States. US return migrants are disadvantaged in terms of health compared to stayers in the destination country and compared to nonmigrants. However, research has rarely considered whether this also holds for internal return migrants. In addition, we know little about heterogeneity in the health of return migrants, particularly whether health differs depending on whether individuals migrated with family members or not. Using representative panel data for the Mexican population from the Mexican Family Life Survey, this article makes several contributions. First, a mental health penalty is found for both US return migrants and internal return migrants compared to nonmigrants in Mexico. Second, I find health disadvantages for return migrants who migrated alone or alone with a child. Conversely, migration with a partner is not significantly related to mental health. A strength of the analytical approach is that longitudinal data, and more specifically indi- vidual fixed-effects models and coarsened exact matching, are used to account for important parts of selection into migration. Overall, this article shows that who indi- viduals migrate with is strongly related to mental health after migrants return home.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The role of cardiovascular risk factors on educational and regional inequalities in mortality in Spain 2016-2022, an analysis using multiple causes of death

  • Pérez-Miguel, Enrique|||0000-0002-6315-7297
  • Trias Llimós, Sergi|||0000-0002-8052-6736
Background: Cardiovascular (CVD) mortality is a key component of life expectancy dynamics. CVD mortality is influenced by well-established risk factors and inequalities across and within sub-populations exist. This paper assesses the role of risk factors on educational and regional inequalities in CVD and all-cause mortality in Spain and its regions (2016-2022). Methods: Using multiple cause-of-death mortality data, we examine two indicators of CVD mortality: 1) Deaths with CVDs as the underlying cause (CVD mortality); and 2) deaths with CVDs as the underlying cause and a mention in the death certificate of any of the following risk factors: diabetes, chronic kidney disease, obesity, lipidemias and hypertension (CVD mortality with risk factors). We use Poisson models to estimate Relative Index of Inequalities (RII) and counterfactual scenarios to estimate potential gains in life expectancy at age 35 resulting from eliminating educational and regional inequalities in risk factors associated with CVDs. Results: CVD deaths with any mentions of risk factors contributed to approximately one-third of CVD deaths and were strongly associated with CVD mortality and CVD mortality inequalities, especially among females. Eliminating inequalities in risk factors associated with CVDs would yield gains in life expectancy (for Spain: 0.19 years among females, 0.14 years among males), with regional variation. These gains were higher than expected compared to its relative weight on CVD and all- cause mortality. Conclusions: Our results suggest that targeting well-established risk factors is an effective strategy for regional health policies, to improve overall life expectancy and CVD mortality and to reduce socioeconomic inequalities.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The association between employment and family histories and caregiving in later life, European findings based on SHARE and ELSA

  • Deindl, Christian
  • Gessa, Giorgio Di
  • Wahrendorf, Morten
  • Damme, Maike van|||0000-0003-1080-9789
  • Spijker, Jeroen|||0000-0002-3957-9553
  • Lacey, Rebecca
  • Xue, Baowen
  • King, Markus
  • McMunn, Anne
Caregiving can be time-consuming, and it can be challenging for caregivers to combine caregiving tasks with other obligations. While we know a lot about the problems of combining informal care with employment and family obligations, past employment and family histories are seldom discussed. This study tries to fill this gap by examining the association between employment and family histories and caregiving in later life. We used pooled data from the Survey of Health, Ageing and Retirement in Europe (SHARE, waves 1 and 2) and the English Longitudinal Study of Ageing (ELSA, waves 2 and 3) and combined them with the life history interviews from both surveys conducted in wave 3. First, we used sequence analysis and cluster analysis to analyze employment, partnership, and children histories between 25 and 50 years of age, separately for men and women. Then, we used logistic regression analysis to examine the relationships between these clusters and informal caregiving at ages 50 and above. Results indicate that women who stayed home (homemakers) and those who were selfemployed were more likely to provide informal care in later life. Partnership histories matter only for men. Men who were separated were less involved in in-household caregiving and more in care provision outside of the household. Furthermore, childless men and women were more likely to be caregivers. Finally, differences in long-term care policies across countries significantly affected the likelihood of informal caregiving for men and women.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inequality measurement for bounded variables

  • Permanyer, Iñaki|||0000-0002-7051-5144
  • Seth, Suman
  • Yalonetzky, Gaston
Many health indicators are bounded, that is, their values lie between a lower and an upper bound. Inequality measurement withbounded variables faces two normative challenges well‐known in the health inequality literature. One is that inequalityrankings may or may not be consistent across admissible attainment and shortfall representations of the variable. The other isthat the set of maximum‐inequality distributions for bounded variables is different from the respective set for variables with noupper bound. Therefore, the ethical criteria for ranking maximum‐inequality distributions with unbounded variables may notbe appropriate for bounded variables. In a novel proposal, we justify an axiom requiring maximum‐inequality distributions ofbounded variables to be ranked equally, irrespective of their means. Then, our axiomatic characterization naturally leads toindices that measure inequality as an increasing function of the observed proportion of maximum attainable inequality for agiven mean. Additionally, our inequality indices rank distributions consistently when switching between attainment andshortfall representations. In our empirical illustration with three health indicators, a starkly different picture of cross‐countryinter‐temporal inequality emerges when traditional inequality indices give way to our proposed normalized inequality indices.
Dipòsit Digital de Documents de la UAB
Publicación

What happens while

  • Nia, Núria
Curt de ficció creat per al projecte VIW (pagines.uab.cat/viw), que investiga l'audiodescripció. Doblat al català i al castellà per l'ECAD, Short fiction film created for the Visuals Into Words (VIW) project (pagines.uab.cat/viw), which researches audio description. Dubbed into Catalan and Spanish by ECAD
ABACUS. Repositorio de Producción Científica
Publicación Artículo científico (JournalArticle)

Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study

  • Díaz Muñoz, Raquel
  • Valle Caballero, María José
  • Sánchez González, Javier
  • Pizarro, Gonzalo
  • García Rubira, Juan Carlos
  • Escalera, Noemí
  • Fuster, Valentín
  • Fernández Jiménez, Rodrigo
  • Ibáñez Cabeza, Borja
Besides its protective effect against neutrophil-mediated injury at reperfusion, intravenous (IV) metoprolol was recently shown to reduce the progression of ischemic injury in a pig model of ST-segment elevation myocardial infarction (STEMI). Here, we tested the hypothesis that IV metoprolol administration in humans with ongoing STEMI blunts the time‑dependent progression of ischemic injury assessed by serial electrocardiogram (ECG) evaluations before reperfusion. The METOCARD-CNIC trial randomized 270 anterior STEMI patients to IV metoprolol or control before reperfusion by percutaneous coronary intervention (PCI). In 139 patients (69 IV metoprolol, 70 controls), two ECGs were available (ECG-1 before randomization, ECG-2 pre-PCI). Between-group ECG differences were analyzed using univariate and multivariate regression models. No significant between-group differences were observed on ECG-1. On ECG-2, patients who received IV metoprolol had a narrower QRS than those in the control group (84 ms vs. 90 ms, p = 0.029), a lower prevalence of QRS distortion (10% vs. 26%, p = 0.017), and a lower sum of anterior and total ST-segment elevation (10.1 mm vs. 13.6 mm, p = 0.014 and 10.4 mm vs. 14.0 mm, p = 0.015, respectively). Adjusted analysis revealed similar results. Significant associations were observed between ECG-2 variables and cardiac magnetic resonance imaging measurements (extent of myocardial edema, infarct size, microvascular obstruction, and left-ventricular ejection fraction) after STEMI. In summary, IV metoprolol administration before reperfusion ameliorates ECG markers of myocardial ischemia in anterior STEMI patients. These data confirm that IV metoprolol is able to reduce ischemic injury and highlight the ability of ECG analysis to provide relevant real-time information on the effect of cardioprotective therapies before reperfusion.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Reduced expression of Paternally Expressed Gene-3 enhances somatic cell reprogramming through mitochondrial activity perturbation

  • Theka, Ilda, 1984-
  • Sottile, Francesco, 1988-
  • Aulicino, Francesco, 1987-
  • García, Álvaro Castells
  • Cosma, Maria Pia
Imprinted genes control several cellular and metabolic processes in embryonic and adult tissues. In particular, paternally expressed gene-3 (Peg3) is active in the adult stem cell population and during muscle and neuronal lineage development. Here we have investigated the role of Peg3 in mouse embryonic stem cells (ESCs) and during the process of somatic cell reprogramming towards pluripotency. Our data show that Peg3 knockdown increases expression of pluripotency genes in ESCs and enhances reprogramming efficiency of both mouse embryonic fibroblasts and neural stem cells. Interestingly, we observed that altered activity of Peg3 correlates with major perturbations of mitochondrial gene expression and mitochondrial function, which drive metabolic changes during somatic cell reprogramming. Overall, our study shows that Peg3 is a regulator of pluripotent stem cells and somatic cell reprogramming., We thank Marie Victoire Neguembor, Martina Pesaresi and Sergi Angel Bonilla Pons for suggestions on the manuscript and Umberto Di Vicino for technical support. We thank Angelique di Domenico and the group of Antonella Consiglio for providing us the OPA1, DRP1 and VDAC1 antibodies. We thank Mari Carmen Ortells and the group of Bill Keyes for providing us the OXPHOS antibody. The pInducer10-mir-RUP-PheS plasmid was a gift from Stephen Elledge (Addgene plasmid # 44011). We are grateful for support from Ministerio de Economia y Competitividad and FEDER funds (SAF2011-28580, BFU2014-54717-P, and BFU2015-71984-ERC to M.P.C.), Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014 SGR1137 to M.P.C.), the European Union's Horizon 2020 research and innovation programme under grant agreement CellViewer No 686637 (to M.P.C.), Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017 and the CERCA Programme/Generalitat de Catalunya (to M.P.C.), People Programme Marie Curie Actions of the European Union's Seventh Framework Programme (FP7/2007-2013/, n° 290123 to I.T.), La Caixa international PhD fellowship (to F.S.), Ministerio de Ciencia e Innovació FPI (to F.A.) and Ministerio de Ciencia e Innovación FPI-Severo Ochoa (to A.C.G).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Genetic load of loss-of-function polymorphic variants in great apes

  • de Valles-Ibáñez, Guillem
  • Hernández Rodríguez, Jéssica, 1983-
  • Prado Martínez, Javier, 1987-
  • Luisi, Pierre, 1985-
  • Marquès i Bonet, Tomàs, 1975-
  • Casals López, Ferran
Loss of function (LoF) genetic variants are predicted to disrupt gene function, and are therefore expected to substantially reduce individual's viability. Knowing the genetic burden of LoF variants in endangered species is of interest for a better understanding of the effects of declining population sizes on species viability. In this study, we have estimated the number of LoF polymorphic variants in six great ape populations, based on whole-genome sequencing data in 79 individuals. Our results show that although the number of functional variants per individual is conditioned by the effective population size, the number of variants with a drastic phenotypic effect is very similar across species. We hypothesize that for those variants with high selection coefficients, differences in effective population size are not important enough to affect the efficiency of natural selection to remove them. We also describe that mostly CpG LoF mutations are shared across species, and an accumulation of LoF variants at olfactory receptor genes in agreement with its pseudogenization in humans and other primate species., The authors thank funding to F.C. by grant SAF2012-35025 from the Ministerio de Economía y Competitividad (Spain) and FEDER and by Direcció General de Recerca, Generalitat de Catalunya (2014SGR-866). T.M.B. is supported by EMBO YIP 2013, MINECO BFU2011-28549, BFU2014-55090-P (FEDER), BFU2015-7116-ERC and BFU2015-6215-ERC (www.mecd.gob.es), NIH U01 MH106874 grant and Fundació Zoo Barcelona.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins

  • Lang, Benjamin
  • Yang, Jae-Seong
  • Garriga-Canut, Mireia
  • Speroni, Silvia
  • Aschern, Moritz
  • Gili, Maria
  • Hoffmann, Tobias, 1990-
  • Tartaglia, Gian Gaetano
  • Maurer, Sebastian
RNA-binding proteins (RBPs) are crucial factors of post-transcriptional gene regulation and their modes of action are intensely investigated. At the center of attention are RNA motifs that guide where RBPs bind. However, sequence motifs are often poor predictors of RBP-RNA interactions in vivo. It is hence believed that many RBPs recognize RNAs as complexes, to increase specificity and regulatory possibilities. To probe the potential for complex formation among RBPs, we assembled a library of 978 mammalian RBPs and used rec-Y2H matrix screening to detect direct interactions between RBPs, sampling > 600 K interactions. We discovered 1994 new interactions and demonstrate that interacting RBPs bind RNAs adjacently in vivo. We further find that the mRNA binding region and motif preferences of RBPs deviate, depending on their adjacently binding interaction partners. Finally, we reveal novel RBP interaction networks among major RNA processing steps and show that splicing impairing RBP mutations observed in cancer rewire spliceosomal interaction networks. The dataset we provide will be a valuable resource for understanding the combinatorial interactions of RBPs with RNAs and the resulting regulatory outcomes., Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2017-85361-P, BFU2014-54278-P, BFU2015-62550-ERC]; Spanish Ministry of Economy and Competitiveness to the EMBL partnership, ‘Centro de Excelencia Severo Ochoa’ [SEV-2012–0208 and SEV‐2015‐0533]; Spanish Ministry of Science and Innovation-State Research Agency (AEI), through the ‘Severo Ochoa Programme for Centres of Excellence in R&D’ [SEV-2015-0533 and CEX2019-000902-S]; CERCA Programme/Generalitat de Catalunya; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie [793135 to B.L.]. Funding for open access charge: Ministerio de Economía y Competitividad.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

(Po)STAC (Polycistronic SunTAg modified CRISPR) enables live-cell and fixed-cell super-resolution imaging of multiple genes

  • Neguembor, Maria Victoria
  • Sebastián Pérez, Rubén
  • Aulicino, Francesco, 1987-
  • Gómez García, Pablo
  • Cosma, Maria Pia, 1970-
  • Lakadamyali, Melike
CRISPR/dCas9-based labeling has allowed direct visualization of genomic regions in living cells. However, poor labeling efficiency and signal-to-background ratio have limited its application to visualize genome organization using super-resolution microscopy. We developed (Po)STAC (Polycistronic SunTAg modified CRISPR) by combining CRISPR/dCas9 with SunTag labeling and polycistronic vectors. (Po)STAC enhances both labeling efficiency and fluorescence signal detected from labeled loci enabling live cell imaging as well as super-resolution fixed-cell imaging of multiple genes with high spatiotemporal resolution., European Union’s Horizon 2020 Research and Innovation Programme [CellViewer No 686637 to M.L., M.P.C.]; Ministerio de Economia y Competitividad [BFU2013–49867-EXP to M.L., M.P.C.]; Fundació Cellex Barcelona (to M.L); European Union Seventh Framework Programme under the European Research Council Grants [337191-MOTORS to M.L.]; ‘Severo Ochoa’ Programme for Centres of Excellence in R&D [SEV-2015- 0522 to M.L.]; Ministerio de Economia y Competitividad and FEDER Funds [BFU2014–54717-P, BFU2015–71984-ERC to M.P.C.]; AGAUR Grant [2014 SGR1137 to M.P.C.]; Spanish Ministry of Economy and Competitiveness (to M.P.C.); Centro de Excelencia Severo Ochoa [2013–2017 to M.P.C.]; CERCA Programme/Generalitat de Catalunya (to M.P.C); Ministerio de Ciencia e Innovacion FPI (to F.A.); People Program (Marie Curie Actions) FP7/2007–2013 under REA grant [608959 to M.V.N.]. Funding for open access charge: European Union’s Horizon 2020 Research and Innovation Programme [CellViewer No 686637].
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Genomic legacy of the African cheetah, Acinonyx jubatus

  • Dobrynin, Pavel
  • Liu, Shiping
  • Tamazian, Gaik
  • Xiong, Zijun
  • Yurchenko, Andrey A.
  • Krasheninnikova, Ksenia
  • Kliver, Sergey
  • Schmidt-Küntzel, Anne
  • Koepfli, Klaus-Peter
  • Johnson, Warren
  • Kuderna, Lukas, 1989-
  • García Pérez, Raquel, 1989-
  • de Manuel, Marc
  • Godinez, Ricardo
  • Komissarov, Aleksey
  • Makunin, Alexey
  • Brukhin, Vladimir
  • Qiu, Weilin
  • Zhou, Long
  • Li, Fang
  • Yi, Jian
  • Driscoll, Carlos
  • Antunes, Agostinho
  • Oleksyk, Taras K.
  • Eizirik, Eduardo
  • Perelman, Polina
  • Roelke, Melody
  • Wildt, David
  • Diekhans, Mark
  • Marquès i Bonet, Tomàs, 1975-
  • Marker, Laurie
  • Bhak, Jong
  • Wang, Jun
  • Zhang, Guojie
  • O&apos;Brien, Stephen J.
BACKGROUND: Patterns of genetic and genomic variance are informative in inferring population history for human, model species and endangered populations. RESULTS: Here the genome sequence of wild-born African cheetahs reveals extreme genomic depletion in SNV incidence, SNV density, SNVs of coding genes, MHC class I and II genes, and mitochondrial DNA SNVs. Cheetah genomes are on average 95 % homozygous compared to the genomes of the outbred domestic cat (24.08 % homozygous), Virunga Mountain Gorilla (78.12 %), inbred Abyssinian cat (62.63 %), Tasmanian devil, domestic dog and other mammalian species. Demographic estimators impute two ancestral population bottlenecks: one >100,000 years ago coincident with cheetah migrations out of the Americas and into Eurasia and Africa, and a second 11,084-12,589 years ago in Africa coincident with late Pleistocene large mammal extinctions. MHC class I gene loss and dramatic reduction in functional diversity of MHC genes would explain why cheetahs ablate skin graft rejection among unrelated individuals. Significant excess of non-synonymous mutations in AKAP4 (p<0.02), a gene mediating spermatozoon development, indicates cheetah fixation of five function-damaging amino acid variants distinct from AKAP4 homologues of other Felidae or mammals; AKAP4 dysfunction may cause the cheetah's extremely high (>80 %) pleiomorphic sperm. CONCLUSIONS:The study provides an unprecedented genomic perspective for the rare cheetah, with potential relevance to the species' natural history, physiological adaptations and unique reproductive disposition., This work was supported in part by a Russian Ministry of Science Mega-grant (no 11.G34.31.0068), a St. Petersburg State University grant (no 1.50.1623.2013), an ICREA grant (no. BFU2014-55090-P), an EMBO YIP 2013 grant (no. BFU2015-7116-ERC) and an MICINN grant (no. BFU2015-6215-ERC). Sample collection and validation of reproductive genes were performed under the permit number 1833/2013, granted by the Namibian Ministry of Environment and Tourism
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Modeling dynamics and function of bone marrow cells in mouse liver regeneration

  • Pedone, Elisa, 1985-
  • Olteanu, Vlad Aris
  • Marucci, Lucia
  • Muñoz-Martin, Maria Isabel
  • Youssef, Sameh A.
  • de Bruin, Alain
  • Cosma, Maria Pia, 1970-
In rodents and humans, the liver can efficiently restore its mass after hepatectomy. This is largely attributed to the proliferation and cell cycle re-entry of hepatocytes. On the other hand, bone marrow cells (BMCs) migrate into the liver after resection. Here, we find that a block of BMC recruitment into the liver severely impairs its regeneration after the surgery. Mobilized hematopoietic stem and progenitor cells (HSPCs) in the resected liver can fuse with hepatocytes, and the hybrids proliferate earlier than the hepatocytes. Genetic ablation of the hybrids severely impairs hepatocyte proliferation and liver mass regeneration. Mathematical modeling reveals a key role of bone marrow (BM)-derived hybrids to drive proliferation in the regeneration process, and predicts regeneration efficiency in experimentally non-testable conditions. In conclusion, BM-derived hybrids are essential to trigger efficient liver regeneration after hepatectomy., This work was supported by an ERC grant (242630-RERE to M.P.C.), the Ministerio de Economia y Competitividad and FEDER funds (SAF2011-28580, BFU2014-54717-P, and BFU2015-71984-ERC to M.P.C.), an AGAUR grant from Secretaria d'Universitats i Investigació del Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014SGR1137 to M.P.C.), an MRC grant (MR/N021444/1 to L.M.), BrisSynBio, BBSRC/EPSRC Synthetic Biology Research Centre (BB/L01386X/1 to L.M.), and Engineering and Physical Sciences Research Council (EP/I013717/1 to V.A.O.). We acknowledge support of the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017 and of the CERCA Programme/Generalitat de Catalunya.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

APC couples neuronal mRNAs to multiple kinesins, EB1, and shrinking microtubule ends for bidirectional mRNA motility

  • Baumann, Sebastian
  • Grawenhoff, Julia
  • Rodrigues, Elsa C.
  • Speroni, Silvia
  • Gili, Maria
  • Komissarov, Artem, 1992-
  • Maurer, Sebastian
Understanding where in the cytoplasm mRNAs are translated is increasingly recognized as being as important as knowing the timing and level of protein expression. mRNAs are localized via active motor-driven transport along microtubules (MTs) but the underlying essential factors and dynamic interactions are largely unknown. Using biochemical in vitro reconstitutions with purified mammalian proteins, multicolor TIRF-microscopy, and interaction kinetics measurements, we show that adenomatous polyposis coli (APC) enables kinesin-1- and kinesin-2-based mRNA transport, and that APC is an ideal adaptor for long-range mRNA transport as it forms highly stable complexes with 3'UTR fragments of several neuronal mRNAs (APC-RNPs). The kinesin-1 KIF5A binds and transports several neuronal mRNP components such as FMRP, PURα and mRNA fragments weakly, whereas the transport frequency of the mRNA fragments is significantly increased by APC. APC-RNP-motor complexes can assemble on MTs, generating highly processive mRNA transport events. We further find that end-binding protein 1 (EB1) recruits APC-RNPs to dynamically growing MT ends and APC-RNPs track shrinking MTs, producing MT minus-end-directed RNA motility due to the high dwell times of APC on MTs. Our findings establish APC as a versatile mRNA-kinesin adaptor and a key factor for the assembly and bidirectional movement of neuronal transport mRNPs., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2017-85361-P], [PID2020-114870GB-I00], [BFU2015-62550-ERC], the Ministerio de Ciencia, Innovación y Universidades and Fondo Social Europeo (FSE) [PRE2018-084501], Juan de la Cierva-Incorporación Program [IJCI-2015-25994], the Human Frontiers in Science Program (HFSP) [RGY0083/2016], and the European Research Council (ERC) [H2020-MSCA-IF-2014-659271.]. We further acknowledge the support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa’ [SEV-2012-0208].
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions

  • Yang, Jae-Seong
  • Garriga-Canut, Mireia
  • Link, Nele
  • Carolis, Carlo
  • Broadbent, Katrina
  • Beltran-Sastre, Violeta
  • Serrano Pubull, Luis, 1982-
  • Maurer, Sebastian
Knowing which proteins and RNAs directly interact is essential for understanding cellular mechanisms. Unfortunately, discovering such interactions is costly and often unreliable. To overcome these limitations, we developed rec-YnH, a new yeast two and three-hybrid-based screening pipeline capable of detecting interactions within protein libraries or between protein libraries and RNA fragment pools. rec-YnH combines batch cloning and transformation with intracellular homologous recombination to generate bait–prey fusion libraries. By developing interaction selection in liquid–gels and using an ORF sequence-based readout of interactions via next-generation sequencing, we eliminate laborious plating and barcoding steps required by existing methods. We use rec-Y2H to simultaneously map interactions of protein domains and reveal novel putative interactors of PAR proteins. We further employ rec-Y2H to predict the architecture of published coprecipitated complexes. Finally, we use rec-Y3H to map interactions between multiple RNA-binding proteins and RNAs—the first time interactions between protein and RNA pools are simultaneously detected., We also acknowledge the support from the Spanish Ministry of Economy and Competitiveness (MINECO) for Juan de la Cierva-Incorporación Programme (IJCI‐2014‐22070) to J.-S.Y., L.S. (BFU2015-63571-P), and S.M. (BFU2014-54278-P and BFU2015-62550-ERC). We further acknowledge support of the Spanish Ministry of Economy and Competitiveness, “Centro de Excelencia Severo Ochoa 2013-2017”, SEV-2012-0208 and the CERCA Programme/Generalitat de Catalunya. This work was funded by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) reference MINECO PE 2013-2016 PN FEDER and the European Regional Development Fund (ERDF). All sequencing was done in the CRG Genomics Core Facility.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Wnt/β-catenin signaling pathway safeguards epigenetic stability and homeostasis of mouse embryonic stem cells

  • Theka, Ilda, 1984-
  • Sottile, Francesco, 1988-
  • Cammisa, Marco
  • Bonnin, Sarah
  • Sanchez-Delgado, Marta
  • Di Vicino, Umberto
  • Neguembor, Maria Victoria
  • Arumugam, Karthik
  • Aulicino, Francesco, 1987-
  • Monk, David
  • Riccio, Andrea
  • Cosma, Maria Pia, 1970-
Mouse embryonic stem cells (mESCs) are pluripotent and can differentiate into cells belonging to the three germ layers of the embryo. However, mESC pluripotency and genome stability can be compromised in prolonged in vitro culture conditions. Several factors control mESC pluripotency, including Wnt/β-catenin signaling pathway, which is essential for mESC differentiation and proliferation. Here we show that the activity of the Wnt/β-catenin signaling pathway safeguards normal DNA methylation of mESCs. The activity of the pathway is progressively silenced during passages in culture and this results into a loss of the DNA methylation at many imprinting control regions (ICRs), loss of recruitment of chromatin repressors, and activation of retrotransposons, resulting into impaired mESC differentiation. Accordingly, sustained Wnt/β-catenin signaling maintains normal ICR methylation and mESC homeostasis and is a key regulator of genome stability., We acknowledge the support from Spanish Ministry of Economy and Competitiveness and FEDER funds (SAF2011-28580, BFU2014-54717-P, BFU2017-86760-P and BFU2015-71984-ERC to M.P.C.), as well as ‘Centro de Excelencia Severo Ochoa 2013–2017’, Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya grant (2014 SGR1137 to M.P.C.), AGAUR (SGR 2017-2019 to M.P.C) and the CERCA Programme/Generalitat de Catalunya (to M.P.C.), the European Union’s Horizon 2020 research and innovation programme under grant agreement CellViewer No 686637 (to M.P.C.), People Programme Marie Curie Actions of the European Union’s Seventh Framework Programme (FP7/2007–2013/, n° 290123 to I.T.), La Caixa international PhD fellowship (to F.S.) and Ministerio de Ciencia e Innovació FPI (to F.A.) and People Program (Marie Curie Actions) FP7/2007–2013 under REA grant (608959 to M.V.N.).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

In vitro reconstitution of kinesin-based, axonal mRNA transport

  • Grawenhoff, Julia
  • Baumann, Sebastian
  • Maurer, Sebastian
Motor protein-driven transport of mRNAs on microtubules and their local translation underlie important neuronal functions such as development, growth cone steering, and synaptic plasticity. While there is abundant data on how membrane-bound cargoes such as vesicles, endosomes, or mitochondria are coupled to motor proteins, surprisingly little is known on the direct interactions of RNA-protein complexes and kinesins or dynein. Provided the potential building blocks are identified, in vitro reconstitutions coupled to Total Internal Reflection Microscopy (TIRF-M) are a powerful and highly sensitive tool to understand how single molecules dynamically interact to assemble into functional complexes. Here we describe how we assemble TIRF-M imaging chambers suitable for the imaging of single protein-RNA complexes. We give advice on optimal sample preparation procedures and explain how a minimal axonal mRNA transport complex can be assembled in vitro. As these assays work at picomolar-range concentrations of proteins and RNAs, they allow the investigation of molecules that cannot be obtained at high concentrations, such as many large or disordered proteins. This now opens the possibility to study how RNA-binding proteins (RBPs), RNAs, and microtubule-associated proteins act together in real-time at single-molecule sensitivity to create cytoplasmic mRNA distributions., This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2017-85361-P], [BFU2014-54278-P], [BFU2015-62550-ERC], by the Juan de la Cierva-Incorporación Program [IJCI-2015-25994], the Human Frontiers in Science Program (HFSP) [RGY0083/2016], the European Research Council (ERC) [H2020-MSCA-IF-2014-659271] and the Ministerio de Ciencia, Innovación y Universidades and Fondo Social Europeo (FSE) [PRE2018-084501]. We further acknowledge support of the Spanish Ministry of Economy and Competitiveness to the EMBL partnership, “Centro de Excelencia Severo Ochoa” [SEV-2012-0208] and [SEV-2015-0533], and the CERCA Programme/Generalitat de Catalunya
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A reconstituted mammalian APC-kinesin complex selectively transports defined packages of axonal mRNAs

  • Baumann, Sebastian
  • Komissarov, Artem, 1992-
  • Gili, Maria
  • Ruprecht, Verena
  • Wieser, Stefan
  • Maurer, Sebastian
Through the asymmetric distribution of messenger RNAs (mRNAs), cells spatially regulate gene expression to create cytoplasmic domains with specialized functions. In neurons, mRNA localization is required for essential processes such as cell polarization, migration, and synaptic plasticity underlying long-term memory formation. The essential components driving cytoplasmic mRNA transport in neurons and mammalian cells are not known. We report the first reconstitution of a mammalian mRNA transport system revealing that the tumor suppressor adenomatous polyposis coli (APC) forms stable complexes with the axonally localized β-actin and β2B-tubulin mRNAs, which are linked to a kinesin-2 via the cargo adaptor KAP3. APC activates kinesin-2, and both proteins are sufficient to drive specific transport of defined mRNA packages. Guanine-rich sequences located in 3'UTRs of axonal mRNAs increase transport efficiency and balance the access of different mRNAs to the transport system. Our findings reveal a minimal set of proteins sufficient to transport mammalian mRNAs., This work was funded by the Spanish Ministry of Economy and Competitiveness (MINECO) (BFU2017-85361-P, BFU2014-54278-P, and BFU2015-62550-ERC), Juan de la Cierva-Incorporación Program (IJCI-2015-25994), the Human Frontiers in Science Program (HFSP) (RGY0083/2016), and the European Research Council (ERC) (H2020-MSCA-IF-2014-659271). V.R. acknowledges support from the Spanish Ministry of Economy and Competitiveness through the Program “Centro de Excelencia Severo Ochoa 2013–2017,” the CERCA Programme/Generalitat de Catalunya, MINECO’s Plan Nacional (BFU2017-86296-P). S.W. acknowledges support from the Spanish Ministry of Economy and Competitiveness through the “Severo Ochoa” program for Centres of Excellence in R&D (SEV-2015-0522), from Fundació Privada Cellex, and from Generalitat de Catalunya through the CERCA program. We further acknowledge support of the Spanish Ministry of Economy and Competitiveness (MEIC) to the EMBL partnership, “Centro de Excelencia Severo Ochoa” (SEV-2012-0208) and the CERCA Programme/Generalitat de Catalunya
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Wnt/Tcf1 pathway restricts embryonic stem cell cycle through activation of the Ink4/Arf locus

  • de Jaime Soguero, Anchel
  • Aulicino, Francesco, 1987-
  • Ertaylan, Gokhan
  • Griego, Anna
  • Cerrato, Aniello
  • Tallam, Aravind
  • del Sol, Antonio
  • Cosma, Maria Pia, 1970-
  • Lluis Vinas, Frederic
Understanding the mechanisms regulating cell cycle, proliferation and potency of pluripotent stem cells guarantees their safe use in the clinic. Embryonic stem cells (ESCs) present a fast cell cycle with a short G1 phase. This is due to the lack of expression of cell cycle inhibitors, which ultimately determines naïve pluripotency by holding back differentiation. The canonical Wnt/β-catenin pathway controls mESC pluripotency via the Wnt-effector Tcf3. However, if the activity of the Wnt/β-catenin controls the cell cycle of mESCs remains unknown. Here we show that the Wnt-effector Tcf1 is recruited to and triggers transcription of the Ink4/Arf tumor suppressor locus. Thereby, the activation of the Wnt pathway, a known mitogenic pathway in somatic tissues, restores G1 phase and drastically reduces proliferation of mESCs without perturbing pluripotency. Tcf1, but not Tcf3, is recruited to a palindromic motif enriched in the promoter of cell cycle repressor genes, such as p15Ink4b, p16Ink4a and p19Arf, which mediate the Wnt-dependent anti-proliferative effect in mESCs. Consistently, ablation of β-catenin or Tcf1 expression impairs Wnt-dependent cell cycle regulation. All together, here we showed that Wnt signaling controls mESC pluripotency and proliferation through non-overlapping functions of distinct Tcf factors., We are grateful for the support from ERC grant (242630-RERE) (MPC), the Ministerio de Economia y Competitividad y FEDER (SAF2011-28580, and BFU2014-54717-P, BFU2015-71984-ERC to MPC), an AGAUR grant from Secretaria d´Universitats i Investigació del Departament d´Economia i Coneixement de la Generalitat de Catalunya (2014SGR1137 to MPC), Ministerio de Ciencia e Innovación FPI (to FA), the European Union's Horizon 2020 research and innovation programme under grant agreement CellViewer No 686637 (to MPC), the Spanish Ministry of Economy and Competitiveness, Centro de Excelencia Severo Ochoa 2013-2017, the CERCA Programme/Generalitat de Catalunya (to MPC); KU Leuven starting grant (STG) and KU Leuven C1 funds (C14/16/078) (to FL), AFR Postdoctoral Grant from the Luxembourg National Research Fund (FNR); ANEMO project N. 4001584/PDR 2012-1 and Dutch Province of Limburg (to GE), Short Term Mobility Award, CNR (to AC).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells

  • Altarche-Xifro, Wassim
  • Di Vicino, Umberto
  • Muñoz-Martin, Maria Isabel
  • Bortolozzi, Analía
  • Bové, Jordi
  • Vila, Miquel
  • Cosma, Maria Pia
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and for which no definitive cure is currently available. Cellular functions in mouse and human tissues can be restored after fusion of bone marrow (BM)-derived cells with a variety of somatic cells. Here, after transplantation of hematopoietic stem and progenitor cells (HSPCs) in the SNpc of two different mouse models of Parkinson's disease, we significantly ameliorated the dopaminergic neuron loss and function. We show fusion of transplanted HSPCs with neurons and with glial cells in the ventral midbrain of Parkinson's disease mice. Interestingly, the hybrids can undergo reprogramming in vivo and survived up to 4 weeks after transplantation, while acquiring features of mature astroglia. These newly generated astroglia produced Wnt1 and were essential for functional rescue of the dopaminergic neurons. Our data suggest that glial-derived hybrids produced upon fusion of transplanted HSPCs in the SNpc can rescue the Parkinson's disease phenotype via a niche-mediated effect, and can be exploited as an efficient cell-therapy approach., We are grateful for the support from a Fundació La Marató de TV3 grant (120530 to M.P.C. and M.V.), an ERC grant (242630-RERE to M.P.C.), Ministerio de Ciencia e Inovación grants (SAF2011-28580, 2014SGR1137 and BFU2015-71984-ERC to M.P.C.), an AGAUR grant (2014 SGR 780 to M.P.C.), Fondo de Investigación Sanitaria-Instituto de Salud Carlos III grants (PI13/01897 to M.V.; CP11/00229 to J.B.), an AGAUR-GRC grant (2014-SGR-1609 to M.V.), European Union Seventh Framework Programme (FP7/2007-2013) under the Marie Curie Intra-European Fellowship (274882 to W.A.X) and Juan de la Cierva fellowship (to W.A.X), Spanish Ministry of Economy and Competitiveness,'Centro de Excelencia Severo Ochoa 2013-2017', SEV-2012-0208.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Super resolution imaging of chromatin in pluripotency, differentiation, and reprogramming

  • Ricci, Maria Aurelia, 1985-
  • Cosma, Maria Pia, 1970-
  • Lakadamyali, Melike
Chromatin fiber organization is essential for gene function in all cell types. Moreover it helps to determine cell fate in embryonic/adult stem cells and in somatic cells undergoing reprogramming to pluripotency. Until now the diffraction limit of light has limited the inspection of the chromatin fiber organization to a level sufficient to understand how it impacts gene function. The development of advanced microscopy methods, such as single molecule localization microscopy, has largely opened a new field of research providing us with the tools to visualize and quantitatively analyze chromatin fiber organization and thus gene activity at nanoscale resolution in single cells., We are grateful for support from Ministerio de Economia y Competitividad and FEDER funds (SAF2011-28580, BFU2014-54717-P, and BFU2015-71984-ERC to MPC, FIS2015-63550-R to ML, BFU2013-49867-EXP to MPC and ML), ERC 337191-MOTORS to ML, AGAUR grant (2014 SGR1137 to MPC), the European Union's Horizon 2020 research and innovation programme under grant agreement CellViewer No. 686637 (to MPC and ML), Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013–2017 and the CERCA Programme/Generalitat de Catalunya (to MPC).
Repisalud
Publicación Artículo científico (JournalArticle)

Metoprolol in Critically Ill Patients With COVID-19.

  • Clemente-Moragón, Agustín
  • Martínez-Milla, Juan
  • Oliver, Eduardo
  • Santos, Arnoldo
  • Flandes, Javier
  • Fernández, Iker
  • Rodríguez-González, Lorena
  • Serrano Del Castillo, Cristina
  • Ioan, Ana-María
  • López-Álvarez, María
  • Gómez-Talavera, Sandra
  • Galán-Arriola, Carlos
  • Fuster, Valentin
  • Pérez-Calvo, César
  • Ibáñez, Borja
Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils. The beta-blocker metoprolol has been shown to ameliorate exacerbated inflammation in the myocardial infarction setting. The purpose of this study was to evaluate the effects of metoprolol on alveolar inflammation and on respiratory function in patients with COVID-19-associated ARDS. A total of 20 COVID-19 patients with ARDS on invasive mechanical ventilation were randomized to metoprolol (15 mg daily for 3 days) or control (no treatment). All patients underwent bronchoalveolar lavage (BAL) before and after metoprolol/control. The safety of metoprolol administration was evaluated by invasive hemodynamic and electrocardiogram monitoring and echocardiography. Metoprolol administration was without side effects. At baseline, neutrophil content in BAL did not differ between groups. Conversely, patients randomized to metoprolol had significantly fewer neutrophils in BAL on day 4 (median: 14.3 neutrophils/µl [Q1, Q3: 4.63, 265 neutrophils/µl] vs median: 397 neutrophils/µl [Q1, Q3: 222, 1,346 neutrophils/µl] in the metoprolol and control groups, respectively; P = 0.016). Metoprolol also reduced neutrophil extracellular traps content and other markers of lung inflammation. Oxygenation (PaO2:FiO2) significantly improved after 3 days of metoprolol treatment (median: 130 [Q1, Q3: 110, 162] vs median: 267 [Q1, Q3: 199, 298] at baseline and day 4, respectively; P = 0.003), whereas it remained unchanged in control subjects. Metoprolol-treated patients spent fewer days on invasive mechanical ventilation than those in the control group (15.5 ± 7.6 vs 21.9 ± 12.6 days; P = 0.17). In this pilot trial, intravenous metoprolol administration to patients with COVID-19-associated ARDS was safe, reduced exacerbated lung inflammation, and improved oxygenation. Repurposing metoprolol for COVID-19-associated ARDS appears to be a safe and inexpensive strategy that can alleviate the burden of the COVID-19 pandemic.
Repisalud
Publicación Artículo científico (JournalArticle)

iSuRe-HadCre is an essential tool for effective conditional genetics.

  • Garcia-Gonzalez, Irene
  • Rocha, Susana F
  • Hamidi, Anahita
  • Garcia-Ortega, Lourdes
  • Regano, Alvaro
  • Sanchez-Muñoz, Maria S
  • Lytvyn, Mariya
  • Garcia-Cabero, Aroa
  • Roig-Soucase, Sergi
  • Schoofs, Hans
  • Castro, Marco
  • Sabata, Helena
  • Potente, Michael
  • Graupera, Mariona
  • Makinen, Taija
  • Benedito, Rui
Methods for modifying gene function at high spatiotemporal resolution in mice have revolutionized biomedical research, with Cre-loxP being the most widely used technology. However, the Cre-loxP technology has several drawbacks, including weak activity, leakiness, toxicity, and low reliability of existing Cre-reporters. This is mainly because different genes flanked by loxP sites (floxed) vary widely in their sensitivity to Cre-mediated recombination. Here, we report the generation, validation, and utility of iSuRe-HadCre, a new dual Cre-reporter and deleter mouse line that avoids these drawbacks. iSuRe-HadCre achieves this through a novel inducible dual-recombinase genetic cascade that ensures that cells expressing a fluorescent reporter had only transient Cre activity, that is nonetheless sufficient to effectively delete floxed genes. iSuRe-HadCre worked reliably in all cell types and for the 13 floxed genes tested. This new tool will enable the precise, efficient, and trustworthy analysis of gene function in entire mouse tissues or in single cells.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Subclinical atherosclerosis and brain health in midlife: Rationale and design of the PESA-Brain study.

  • Tristão-Pereira, Catarina
  • Fuster, Valentin
  • Lopez-Jimenez, Alejandro
  • Fernández-Pena, Alberto
  • Semerano, Aurora
  • Fernandez-Nueda, Irene
  • Garcia-Lunar, Ines
  • Ayuso, Carmen
  • Sanchez-Gonzalez, Javier
  • Ibanez, Borja
  • Gispert, Juan Domingo
  • Cortes-Canteli, Marta
  • Tristão-Pereira, Catarina
  • Fuster, Valentin
  • Lopez-Jimenez, Alejandro
  • Fernández-Pena, Alberto
  • Semerano, Aurora
  • Fernandez-Nueda, Irene
  • Garcia-Lunar, Ines
  • Ayuso, Carmen
  • Sanchez-Gonzalez, Javier
  • Ibanez, Borja
  • Gispert, Juan Domingo
  • Cortes-Canteli, Marta
Cognitive decline and dementia have been reportedly linked to atherosclerosis, the main cause of cardiovascular disease. Cohort studies identifying early brain alterations associated with subclinical atherosclerosis are warranted to understand the potential of prevention strategies before cerebral damage becomes symptomatic and irreversible. The Progression of Early Subclinical Atherosclerosis (PESA) study is a longitudinal observational cohort study that recruited 4,184 asymptomatic middle-aged individuals (40-54 years) in 2010 in Madrid (Spain) to thoroughly characterize subclinical atherosclerosis development over time. In this framework, the PESA-Brain study has been designed to identify early structural, functional and vascular brain changes associated with midlife atherosclerosis and cardiovascular risk factors. The PESA-Brain study targets 1,000 participants at the 10-year follow-up PESA visit and consists of thorough neuropsychological testing, advanced multimodal neuroimaging, and quantification of blood-based neuropathological biomarkers. We hypothesize that, in middle-age, the presence of cardiovascular risk factors and a high burden of subclinical atherosclerosis will be associated with structural, functional and vascular brain alterations, greater amyloid burden and subtle cognitive impairment. We further hypothesize that the link between subclinical atherosclerosis and poor brain health in midlife will be mediated by cerebrovascular pathology and intracranial atherosclerosis. Enrollment dates: The PESA-Brain study started in October 2020 and is estimated to be completed by December 2024. Conclusion: This study is in a unique position to unveil novel relationships between cardiovascular and brain alterations in the health-to-disease transition, which may have important implications for interventional and therapeutic approaches.
Repisalud
Publicación Artículo científico (JournalArticle)

Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration.

  • Moiseeva, Victoria
  • Cisneros, Andrés
  • Sica, Valentina
  • Deryagin, Oleg
  • Lai, Yiwei
  • Jung, Sascha
  • Andrés, Eva
  • An, Juan
  • Segalés, Jessica
  • Ortet, Laura
  • Lukesova, Vera
  • Volpe, Giacomo
  • Benguria, Alberto
  • Dopazo, Ana
  • Benitah, Salvador Aznar
  • Urano, Yasuteru
  • Del Sol, Antonio
  • Esteban, Miguel A
  • Ohkawa, Yasuyuki
  • Serrano, Antonio L
  • Perdiguero, Eusebio
  • Munoz-Canoves, Pura
Tissue regeneration requires coordination between resident stem cells and local niche cells1,2. Here we identify that senescent cells are integral components of the skeletal muscle regenerative niche that repress regeneration at all stages of life. The technical limitation of senescent-cell scarcity3 was overcome by combining single-cell transcriptomics and a senescent-cell enrichment sorting protocol. We identified and isolated different senescent cell types from damaged muscles of young and old mice. Deeper transcriptome, chromatin and pathway analyses revealed conservation of cell identity traits as well as two universal senescence hallmarks (inflammation and fibrosis) across cell type, regeneration time and ageing. Senescent cells create an aged-like inflamed niche that mirrors inflammation associated with ageing (inflammageing4) and arrests stem cell proliferation and regeneration. Reducing the burden of senescent cells, or reducing their inflammatory secretome through CD36 neutralization, accelerates regeneration in young and old mice. By contrast, transplantation of senescent cells delays regeneration. Our results provide a technique for isolating in vivo senescent cells, define a senescence blueprint for muscle, and uncover unproductive functional interactions between senescent cells and stem cells in regenerative niches that can be overcome. As senescent cells also accumulate in human muscles, our findings open potential paths for improving muscle repair throughout life.
Repisalud
Publicación Artículo científico (JournalArticle)

Mechanisms of fibrous cap formation in atherosclerosis.

  • Alonso-Herranz, Laura
  • Albarrán-Juárez, Julián
  • Bentzon, Jacob Fog
The fibrous cap is formed by smooth muscle cells that accumulate beneath the plaque endothelium. Cap rupture is the main cause of coronary thrombosis, leading to infarction and sudden cardiac death. Therefore, the qualities of the cap are primary determinants of the clinical outcome of coronary and carotid atherosclerosis. In this mini-review, we discuss current knowledge about the formation of the fibrous cap, including cell recruitment, clonal expansion, and central molecular signaling pathways. We also examine the differences between mouse and human fibrous caps and explore the impact of anti-atherosclerotic therapies on the state of the fibrous cap. We propose that the cap should be understood as a neo-media to substitute for the original media that becomes separated from the surface endothelium during atherogenesis and that embryonic pathways involved in the development of the arteria media contribute to cap formation.
Repisalud
Publicación Artículo científico (JournalArticle)

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue.

  • Gonzalez-Franquesa, Alba
  • Gama-Perez, Pau
  • Kulis, Marta
  • Szczepanowska, Karolina
  • Dahdah, Norma
  • Moreno-Gomez, Sonia
  • Latorre-Pellicer, Ana
  • Fernández-Ruiz, Rebeca
  • Aguilar-Mogas, Antoni
  • Hoffman, Anne
  • Monelli, Erika
  • Samino, Sara
  • Miró-Blanch, Joan
  • Oemer, Gregor
  • Duran, Xavier
  • Sanchez-Rebordelo, Estrella
  • Schneeberger, Marc
  • Obach, Merce
  • Montane, Joel
  • Castellano, Giancarlo
  • Chapaprieta, Vicente
  • Sun, Wenfei
  • Navarro, Lourdes
  • Prieto, Ignacio
  • Castaño, Carlos
  • Novials, Anna
  • Gomis, Ramon
  • Monsalve, Maria
  • Claret, Marc
  • Graupera, Mariona
  • Soria, Guadalupe
  • Wolfrum, Christian
  • Vendrell, Joan
  • Fernández-Veledo, Sonia
  • Enriquez, Jose Antonio
  • Carracedo, Angel
  • Perales, José Carlos
  • Nogueiras, Rubén
  • Herrero, Laura
  • Trifunovic, Aleksandra
  • Keller, Markus A
  • Yanes, Oscar
  • Sales-Pardo, Marta
  • Guimerà, Roger
  • Blüher, Matthias
  • Martín-Subero, José Ignacio
  • Garcia-Roves, Pablo M
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, proteomic, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most obesity and overnutrition-related pathological features were successfully reverted, we observed a high degree of metabolic dysfunction in visceral white adipose tissue, characterized by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and an apparent global healthy phenotype, obesity triggered a cascade of events in visceral adipose tissue progressing from mitochondrial metabolic and proteostatic alterations to widespread cellular stress, which compromises its biosynthetic and recycling capacity. In humans, weight loss after bariatric surgery showed a transcriptional signature in visceral adipose tissue similar to our mouse model of obesity reversion. Overall, our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in visceral adipose tissue.
Repisalud
Publicación Artículo científico (JournalArticle)

Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases.

  • Devesa, Ana
  • Delgado, Victoria
  • Valkovic, Ladislav
  • Lima, Joao A C
  • Nagel, Eike
  • Ibanez, Borja
  • Raman, Betty
Cardiometabolic diseases encompass a group of conditions characterized by metabolic and inflammatory abnormalities that increase the risk of diabetes and cardiovascular disease. These syndromes involve multiple organs, including the heart, arterial system, brain, skeletal muscle, adipose tissue, hematopoietic system, liver, kidneys, and pancreas. The crosstalk between these organs contributes to the development of disease. Advances in imaging techniques, such as magnetic resonance imaging, magnetic resonance spectroscopy, computed tomography, and positron emission tomography, have revolutionized the evaluation of these conditions. Hybrid imaging modalities, such as positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging, provide unique insights into the anatomy and metabolic alterations occurring in response to cardiometabolic risk factors. These methods are particularly valuable for assessing multisystemic involvement and interorgan crosstalk, revealing critical interactions such as the brain-heart axis, the heart-liver axis, and the fat-muscle-heart dynamics. This review discusses the role of state-of-the-art imaging techniques in evaluating the pathophysiological mechanisms underlying these complex syndromes and the clinical applications of the different imaging techniques in the assessment of cardiometabolic diseases.
Repisalud
Publicación Artículo científico (JournalArticle)

Stroma-derived miR-214 coordinates tumor dissemination.

  • Orso, Francesca
  • Virga, Federico
  • Dettori, Daniela
  • Dalmasso, Alberto
  • Paradzik, Mladen
  • Savino, Aurora
  • Pomatto, Margherita A C
  • Quirico, Lorena
  • Cucinelli, Stefania
  • Coco, Martina
  • Mareschi, Katia
  • Fagioli, Franca
  • Salmena, Leonardo
  • Camussi, Giovanni
  • Provero, Paolo
  • Poli, Valeria
  • Mazzone, Massimiliano
  • Pandolfi, Pier Paolo
  • Taverna, Daniela
BACKGROUND Tumor progression is based on a close interaction between cancer cells and Tumor MicroEnvironment (TME). Here, we focus on the role that Cancer Associated Fibroblasts (CAFs), Mesenchymal Stem Cells (MSCs) and microRNAs (miRs) play in breast cancer and melanoma malignancy. METHODS We used public databases to investigate miR-214 expression in the stroma compartment of primary human samples and evaluated tumor formation and dissemination following tumor cell injections in miR-214 overexpressing (miR-214over) and knock out (miR-214ko) mice. In addition, we dissected the impact of Conditioned Medium (CM) or Extracellular Vesicles (EVs) derived from miR-214-rich or depleted stroma cells on cell metastatic traits. RESULTS We evidence that the expression of miR-214 in human cancer or metastasis samples mostly correlates with stroma components and, in particular, with CAFs and MSCs. We present data revealing that the injection of tumor cells in miR-214over mice leads to increased extravasation and metastasis formation. In line, treatment of cancer cells with CM or EVs derived from miR-214-enriched stroma cells potentiate cancer cell migration/invasion in vitro. Conversely, dissemination from tumors grown in miR-214ko mice is impaired and metastatic traits significantly decreased when CM or EVs from miR-214-depleted stroma cells are used to treat cells in culture. Instead, extravasation and metastasis formation are fully re-established when miR-214ko mice are pretreated with miR-214-rich EVs of stroma origin. Mechanistically, we also show that tumor cells are able to induce miR-214 production in stroma cells, following the activation of IL-6/STAT3 signaling, which is then released via EVs subsequently up-taken by cancer cells. Here, a miR-214-dependent pro-metastatic program becomes activated. CONCLUSIONS Our findings highlight the relevance of stroma-derived miR-214 and its release in EVs for tumor dissemination, which paves the way for miR-214-based therapeutic interventions targeting not only tumor cells but also the TME.
Repisalud
Publicación Artículo científico (JournalArticle)

A Chemical Screen Identifies Compounds Capable of Selecting for Haploidy in Mammalian Cells

  • Olbrich, Teresa
  • Vega-Sendino, Maria
  • Murga, Matilde
  • de Carcer Diez, Guillermo
  • Malumbres Martinez, Marcos
  • Ortega Jimenez, Sagrario
  • Ruiz, Sergio
  • Fernandez-Capetillo, Oscar
The recent availability of somatic haploid cell lines has provided a unique tool for genetic studies in mammals. However, the percentage of haploid cells rapidly decreases in these cell lines, which we recently showed is due to their overgrowth by diploid cells present in the cultures. Based on this property, we have now performed a phenotypic chemical screen in human haploid HAP1 cells aiming to identify compounds that facilitate the maintenance of haploid cells. Our top hit was 10-Deacetyl-baccatin-III (DAB), a chemical precursor in the synthesis of Taxol, which selects for haploid cells in HAP1 and mouse haploid embryonic stem cultures. Interestingly, DAB also enriches for diploid cells in mixed cultures of diploid and tetraploid cells, including in the colon cancer cell line DLD-1, revealing a general strategy for selecting cells with lower ploidy in mixed populations of mammalian cells.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Brain JNK and metabolic disease.

  • Nogueiras, Rubén
  • Sabio, Guadalupe
Obesity, which has long since reached epidemic proportions worldwide, is associated with long-term stress to a variety of organs and results in diseases including type 2 diabetes. In the brain, overnutrition induces hypothalamic stress associated with the activation of several signalling pathways, together with central insulin and leptin resistance. This central action of nutrient overload appears very rapidly, suggesting that nutrition-induced hypothalamic stress is a major upstream initiator of obesity and associated diseases. The cellular response to nutrient overload includes the activation of the stress-activated c-Jun N-terminal kinases (JNKs) JNK1, JNK2 and JNK3, which are widely expressed in the brain. Here, we review recent findings on the regulation and effects of these kinases, with particular focus on the hypothalamus, a key brain region in the control of energy and glucose homeostasis. JNK1 blocks the hypothalamic-pituitary-thyroid axis, reducing energy expenditure and promoting obesity. Recently, opposing roles have been identified for JNK1 and JNK3 in hypothalamic agouti gene-related protein (AgRP) neurons: while JNK1 activation in AgRP neurons induces feeding and weight gain and impairs insulin and leptin signalling, JNK3 (also known as MAPK10) deletion in the same neuronal population produces very similar effects. The opposing roles of these kinases, and the unknown role of hypothalamic JNK2, reflect the complexity of JNK biology. Future studies should address the specific function of each kinase, not only in different neuronal subsets, but also in non-neuronal cells in the central nervous system. Decoding the puzzle of brain stress kinases will help to define the central stimuli and mechanisms implicated in the control of energy balance. Graphical abstract.
Repisalud
Publicación Artículo científico (JournalArticle)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.

  • Devesa, Ana
  • Camblor Blasco, Andrea
  • Pello Lázaro, Ana María
  • Askari, Elham
  • Lapeña, Gregoria
  • Gómez Talavera, Sandra
  • Taibo Urquía, Mikel
  • Rodríguez Olleros, Celia
  • Tuñón, José
  • Ibáñez, Borja
  • Aceña, Álvaro
As evidenced by scintigraphy imaging, the prevalence of transthyretin (TTR) cardiac amyloidosis in heart failure patients with preserved ejection fraction (HFpEF) and left ventricular hypertrophy (LVH) ranges between 13% and 19%. The natural evolution of cardiac amyloidosis begins with the deposition of amyloid material in the myocardium, with LVH ensuing at later stages. With current imaging modalities, it is possible to detect TTR cardiac amyloidosis before the hypertrophic stage. The aim of this study was to determine the prevalence of TTR cardiac amyloidosis in HFpEF patients without LVH. The study prospectively enrolled patients admitted for HF with LV ejection fraction (LVEF) ≥ 50% and LV wall thickness <12 mm. TTR cardiac amyloidosis was diagnosed according to accepted criteria, which include positive cardiac 99-Tc-DPD scintigraphy in the absence of monoclonal protein expansion in blood. Transthyretin gene sequencing was performed in positive patients. From July 2017 to January 2020, 329 patients with HFpEF and LV thickness <12 mm were identified. After exclusions, 58 patients completed the study with cardiac scintigraphy (79 years, 54% men; median LVEF 60% and LV wall thickness 10.5 mm). Three patients (5.2%) were positive for TTR cardiac amyloidosis; genetic analysis excluded the presence of hereditary TTR amyloidosis. Positive patients baseline characteristics (84 years, 67% men, LVEF 60%, and LV wall thickness 11 mm) were similar to patients without TTR, except for troponin levels (0.05 vs. 0.02 ng/mL, P = 0.03) and glomerular filtration rate (82 vs. 60 mL/min, P = 0.032), which were higher in TTR patients. In a cohort of patients with HFpEF without LVH, the prevalence of TTR cardiac amyloidosis was 5%. Early diagnosis of cardiac involvement in TTR amyloidosis (before manifest LVH) would seem recommendable because newly approved specific treatments can prevent additional deposition of amyloid material.
Repisalud
Publicación Artículo científico (JournalArticle)

Influence of Subclinical Atherosclerosis Burden and Progression on Mortality.

  • Fuster, Valentin
  • García-Álvarez, Ana
  • Devesa, Ana
  • Mass, Virginia
  • Owen, Ruth
  • Quesada, Antonio
  • Fuster, José J
  • García-Lunar, Inés
  • Pocock, Stuart
  • Sánchez-González, Javier
  • Sartori, Samantha
  • Peyra, Carlos
  • Andres, Vicente
  • Muntendam, Pieter
  • Ibanez, Borja
Atherosclerosis is a dynamic process. There is little evidence regarding whether quantification of atherosclerosis extent and progression, particularly in the carotid artery, in asymptomatic individuals predicts all-cause mortality. This study sought to evaluate the independent predictive value (beyond cardiovascular risk factors) of subclinical atherosclerosis burden and progression and all-cause mortality. A population of 5,716 asymptomatic U.S. adults (mean age 68.9 years, 56.7% female) enrolled between 2008 and 2009 in the BioImage (A Clinical Study of Burden of Atherosclerotic Disease in an At Risk Population) study underwent examination by vascular ultrasound to quantify carotid plaque burden (cPB) (the sum of right and left carotid plaque areas) and by computed tomography for coronary artery calcium (CAC). Follow-up carotid vascular ultrasound was performed on 732 participants a median of 8.9 years after the baseline exam. All participants were followed up for all-cause mortality, the primary outcome. Trend HRs are the per-tertile increase in each variable. Over a median 12.4 years' follow-up, 901 (16%) participants died. After adjustment for cardiovascular risk factors and background medication, baseline cPB and CAC score were both significantly associated with all-cause mortality (fully adjusted trend HR: 1.23; 95% CI: 1.16-1.32; and HR: 1.15; 95% CI: 1.08-1.23), respectively (both P < 0.001), thus providing additional prognostic value. cPB performed better than CAC score. In participants with a second vascular ultrasound evaluation, median cPB progressed from 29.2 to 91.3 mm. cPB progression was significantly associated with all-cause mortality after adjusting for cardiovascular risk factors and baseline cPB (HR: 1.03; 95% CI: 1.01-1.04 per absolute 10-mm change; P = 0.01). Subclinical atherosclerosis burden (cPB and CAC) in asymptomatic individuals was independently associated with all-cause mortality. Moreover, atherosclerosis progression was independently associated with all-cause mortality.
Repisalud
Publicación Artículo científico (JournalArticle)

Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors.

  • Devesa, Ana
  • Fuster, Valentin
  • García-Lunar, Inés
  • Oliva, Belén
  • García-Alvarez, Ana
  • Moreno-Arciniegas, Andrea
  • Vazirani, Ravi
  • Pérez-Herreras, Cristina
  • Marina, Pablo
  • Bueno, Héctor
  • Fernández-Friera, Leticia
  • Fernández-Ortiz, Antonio
  • Sanchez-Gonzalez, Javier
  • Ibanez, Borja
  • Devesa, Ana
  • Fuster, Valentin
  • García-Lunar, Inés
  • Oliva, Belén
  • García-Alvarez, Ana
  • Moreno-Arciniegas, Andrea
  • Vazirani, Ravi
  • Pérez-Herreras, Cristina
  • Marina, Pablo
  • Bueno, Héctor
  • Fernández-Friera, Leticia
  • Fernández-Ortiz, Antonio
  • Sanchez-Gonzalez, Javier
  • Ibanez, Borja
In patients with ischemic heart disease, coronary microvascular dysfunction is associated with cardiovascular risk factors and poor prognosis; however, data from healthy individuals are scarce. The purpose of this study was to assess the impact of cardiovascular risk factors and subclinical atherosclerosis on coronary microvascular function in middle-aged asymptomatic individuals. Myocardial perfusion was measured at rest and under stress using cardiac magnetic resonance in 453 individuals and used to generate myocardial blood flow (MBF) maps and calculate myocardial perfusion reserve (MPR). Subclinical atherosclerosis was assessed using 3-dimensional vascular ultrasound of the carotid and femoral arteries and coronary artery calcium scoring at baseline and at 3-year follow-up. Median participant age was 52.6 years (range: 48.9-55.8 years), and 84.5% were male. After adjusting for age and sex, rest MBF was directly associated with the number of the metabolic syndrome components present (elevated waist circumference, systolic and diastolic blood pressure, fasting glucose, and triglycerides and low high-density lipoprotein cholesterol), insulin resistance (homeostatic model assessment for insulin resistance), and presence of diabetes. MPR was reduced in the presence of several metabolic syndrome components, elevated homeostatic model assessment for insulin resistance, and diabetes. Stress MBF was inversely associated with coronary artery calcium presence and with global plaque burden. Higher stress MBF and MPR were associated with less atherosclerosis progression (increase in plaque volume) at 3 years. In asymptomatic middle-aged individuals free of known cardiovascular disease, the presence of cardiometabolic risk factors and systemic (poly-vascular) subclinical atherosclerosis are associated with impaired coronary microvascular function. Better coronary microvascular function reduces atherosclerosis progression at follow-up. (Progression of Early Subclinical Atherosclerosis [PESA]; NCT01410318).
Repisalud
Publicación Artículo científico (JournalArticle)

Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot Study.

  • Camblor Blasco, Andrea
  • Devesa, Ana
  • Nieto Roca, Luis
  • Gómez-Talavera, Sandra
  • Lumpuy-Castillo, Jairo
  • Pello Lázaro, Ana María
  • Llanos Jiménez, Lucía
  • Sánchez González, Javier
  • Lorenzo, Óscar
  • Tuñón, Jose
  • Ibáñez, Borja
  • Aceña, Álvaro
ATTR-CM is becoming more prevalent, and disease-modifying therapy has been investigated in recent years with promising results. Diflunisal has shown TTR-stabilizing properties assessed by biomarkers and echocardiography, but there are no trials addressing the evolution of morphological changes with CMR. AMILCA-DIFLU is an exploratory pilot study prospective, single-center, non-randomized, open-label clinical trial. Patients diagnosed with ATTR-CM underwent clinical, functional, biochemical and imaging assessment before and one year after diflunisal therapy initiation. Of the twelve ATTR-CM patients included, only nine patients completed treatment and study protocol in 12 months. To increase the sample size, we included seven real-world patients with one year of diflunisal treatment. Among the group of patients who completed treatment, diflunisal therapy did not show improvement in cardiac disease status as assessed by many cardiac and inflammatory biomarkers, 6MWT and CMR parameters after one year of treatment. However, a non-significant trend towards stabilization of CMR parameters such as LVEF, ECV and T2 at one year was found. When comparing the group of patients who completed diflunisal therapy and those who did not, a significant decrease in the distance performed in the 6MWT was found in the group of patients who completed treatment at one year (-14 ± 81.8 vs. -173 ± 122.2; = 0.032). Diflunisal was overall well tolerated, showing only a statistically significant worsening in renal function in the group of diflunisal-treatment patients with no clinical relevance or need for treatment discontinuation. In patients with ATTR-CM, treatment with diflunisal was overall well tolerated and tended to stabilize or slow down amyloid cardiac disease progression assessed by CMR parameters, cardiac and inflammatory biomarkers and functional capacity.
Repisalud
Publicación Artículo científico (JournalArticle)

Neutrophil "plucking" on megakaryocytes drives platelet production and boosts cardiovascular disease.

  • Petzold, Tobias
  • Zhang, Zhe
  • Ballesteros, Ivan
  • Saleh, Inas
  • Polzin, Amin
  • Thienel, Manuela
  • Liu, Lulu
  • Ul Ain, Qurrat
  • Ehreiser, Vincent
  • Weber, Christian
  • Kilani, Badr
  • Mertsch, Pontus
  • Götschke, Jeremias
  • Cremer, Sophie
  • Fu, Wenwen
  • Lorenz, Michael
  • Ishikawa-Ankerhold, Hellen
  • Raatz, Elisabeth
  • El-Nemr, Shaza
  • Görlach, Agnes
  • Marhuenda, Esther
  • Stark, Konstantin
  • Pircher, Joachim
  • Stegner, David
  • Gieger, Christian
  • Schmidt-Supprian, Marc
  • Gaertner, Florian
  • Almendros, Isaac
  • Kelm, Malte
  • Schulz, Christian
  • Hidalgo, Andres
  • Massberg, Steffen
Intravascular neutrophils and platelets collaborate in maintaining host integrity, but their interaction can also trigger thrombotic complications. We report here that cooperation between neutrophil and platelet lineages extends to the earliest stages of platelet formation by megakaryocytes in the bone marrow. Using intravital microscopy, we show that neutrophils "plucked" intravascular megakaryocyte extensions, termed proplatelets, to control platelet production. Following CXCR4-CXCL12-dependent migration towards perisinusoidal megakaryocytes, plucking neutrophils actively pulled on proplatelets and triggered myosin light chain and extracellular-signal-regulated kinase activation through reactive oxygen species. By these mechanisms, neutrophils accelerate proplatelet growth and facilitate continuous release of platelets in steady state. Following myocardial infarction, plucking neutrophils drove excessive release of young, reticulated platelets and boosted the risk of recurrent ischemia. Ablation of neutrophil plucking normalized thrombopoiesis and reduced recurrent thrombosis after myocardial infarction and thrombus burden in venous thrombosis. We establish neutrophil plucking as a target to reduce thromboischemic events.
Repisalud
Publicación Artículo científico (JournalArticle)

Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target.

  • Díaz-Guerra, Anabel
  • Villena-Gutierrez, Rocio
  • Clemente-Moragón, Agustín
  • Gomez, Monica
  • Oliver, Eduardo
  • Fernández-Tocino, Miguel
  • Galan-Arriola, Carlos
  • Cádiz, Laura
  • Ibáñez, Borja
BACKGROUND Anthracycline-induced cardiotoxicity (AIC) debilitates quality of life in cancer survivors. Serial characterizations are lacking of the molecular processes occurring with AIC. OBJECTIVES The aim of this study was to characterize AIC progression in a mouse model from early (subclinical) to advanced heart failure stages, with an emphasis on cardiac metabolism and mitochondrial structure and function. METHODS CD1 mice received 5 weekly intraperitoneal doxorubicin injections (5 mg/kg) and were followed by serial echocardiography for 15 weeks. At 1, 9, and 15 weeks after the doxorubicin injections, mice underwent fluorodeoxyglucose positron emission tomography, and hearts were extracted for microscopy and molecular analysis. RESULTS Cardiac atrophy was evident at 1 week post-doxorubicin (left ventricular [LV] mass 117 ± 26 mg vs 97 ± 25 mg at baseline and 1 week, respectively; P < 0.001). Cardiac mass nadir was observed at week 3 post-doxorubicin (79 ± 16 mg; P = 0.002 vs baseline), remaining unchanged thereafter. Histology confirmed significantly reduced cardiomyocyte area (167 ± 19 μm2 in doxorubicin-treated mice vs 211 ± 26 μm2 in controls; P = 0.004). LV ejection fraction declined from week 6 post-doxorubicin (49% ± 9% vs 61% ± 9% at baseline; P < 0.001) until the end of follow-up at 15 weeks (43% ± 8%; P < 0.001 vs baseline). At 1 week post-doxorubicin, when LV ejection fraction remained normal, reduced cardiac metabolism was evident from down-regulated markers of fatty acid oxidation and glycolysis. Metabolic impairment continued to the end of follow-up in parallel with reduced mitochondrial adenosine triphosphate production. A transient early up-regulation of nutrient-sensing and mitophagy markers were observed, which was associated with mitochondrial enlargement. Later stages, when mitophagy was exhausted, were characterized by overt mitochondrial fragmentation. CONCLUSIONS Cardiac atrophy, global hypometabolism, early transient-enhanced mitophagy, biogenesis, and nutrient sensing constitute candidate targets for AIC prevention.
Repisalud
Publicación Artículo científico (JournalArticle)

The Evolving Landscape of Brain Metastasis.

  • Valiente, Manuel
  • Ahluwalia, Manmeet S
  • Boire, Adrienne
  • Brastianos, Priscilla K
  • Goldberg, Sarah B
  • Lee, Eudocia Q
  • Le Rhun, Emilie
  • Preusser, Matthias
  • Winkler, Frank
  • Soffietti, Riccardo
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Stress kinases in the development of liver steatosis and hepatocellular carcinoma.

  • Cicuéndez, Beatriz
  • Ruiz-Garrido, Irene
  • Mora, Alfonso
  • Sabio, Guadalupe
Non-alcoholic fatty liver disease (NAFLD) is an important component of metabolic syndrome and one of the most prevalent liver diseases worldwide. This disorder is closely linked to hepatic insulin resistance, lipotoxicity, and inflammation. Although the mechanisms that cause steatosis and chronic liver injury in NAFLD remain unclear, a key component of this process is the activation of stress-activated kinases (SAPKs), including p38 and JNK in the liver and immune system. This review summarizes findings which indicate that the dysregulation of stress kinases plays a fundamental role in the development of steatosis and are important players in inducing liver fibrosis. To avoid the development of steatohepatitis and liver cancer, SAPK activity must be tightly regulated not only in the hepatocytes but also in other tissues, including cells of the immune system. Possible cellular mechanisms of SAPK actions are discussed.
Repisalud
Publicación Artículo científico (JournalArticle)

Rewiring Vascular Metabolism Prevents Sudden Death due to Aortic Ruptures-Brief Report.

  • Oller, Jorge
  • Gabandé-Rodríguez, Enrique
  • Roldan-Montero, Raquel
  • Ruiz-Rodríguez, María Jesús
  • Redondo, Juan Miguel
  • Martín-Ventura, José Luís
  • Mittelbrunn, María
The goal of this study was to determine whether boosting mitochondrial respiration prevents the development of fatal aortic ruptures triggered by atherosclerosis and hypertension. Ang-II (angiotensin-II) was infused in ApoE (Apolipoprotein E)-deficient mice fed with a western diet to induce acute aortic aneurysms and lethal ruptures. We found decreased mitochondrial respiration and mitochondrial proteins in vascular smooth muscle cells from murine and human aortic aneurysms. Boosting NAD levels with nicotinamide riboside reduced the development of aortic aneurysms and sudden death by aortic ruptures. Targetable vascular metabolism is a new clinical strategy to prevent fatal aortic ruptures and sudden death in patients with aortic aneurysms.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Unidirectional association of clonal hematopoiesis with atherosclerosis development.

  • Díez-Díez, Miriam
  • Ramos-Neble, Beatriz L
  • de la Barrera, Jorge
  • Silla-Castro, J C
  • Quintas, Ana
  • Vázquez, Enrique
  • Rey-Martín, M Ascensión
  • Izzi, Benedetta
  • Sánchez-García, Lucía
  • García-Lunar, Inés
  • Mendieta, Guiomar
  • Mass, Virginia
  • Gómez-López, Nuria
  • Espadas, Cristina
  • González, Gema
  • Quesada, Antonio J
  • García-Álvarez, Ana
  • Fernández-Ortiz, Antonio
  • Lara-Pezzi, Enrique
  • Dopazo, Ana
  • Sánchez-Cabo, Fátima
  • Ibáñez, Borja
  • Andrés, Vicente
  • Fuster, Valentín
  • Fuster, José J
Clonal hematopoiesis, a condition in which acquired somatic mutations in hematopoietic stem cells lead to the outgrowth of a mutant hematopoietic clone, is associated with a higher risk of hematological cancer and a growing list of nonhematological disorders, most notably atherosclerosis and associated cardiovascular disease. However, whether accelerated atherosclerosis is a cause or a consequence of clonal hematopoiesis remains a matter of debate. Some studies support a direct contribution of certain clonal hematopoiesis-related mutations to atherosclerosis via exacerbation of inflammatory responses, whereas others suggest that clonal hematopoiesis is a symptom rather than a cause of atherosclerosis, as atherosclerosis or related traits may accelerate the expansion of mutant hematopoietic clones. Here we combine high-sensitivity DNA sequencing in blood and noninvasive vascular imaging to investigate the interplay between clonal hematopoiesis and atherosclerosis in a longitudinal cohort of healthy middle-aged individuals. We found that the presence of a clonal hematopoiesis-related mutation confers an increased risk of developing de novo femoral atherosclerosis over a 6-year period, whereas neither the presence nor the extent of atherosclerosis affects mutant cell expansion during this timeframe. These findings indicate that clonal hematopoiesis unidirectionally promotes atherosclerosis, which should help translate the growing understanding of this condition into strategies for the prevention of atherosclerotic cardiovascular disease in individuals exhibiting clonal hematopoiesis.
Repisalud
Publicación Artículo científico (JournalArticle)

The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy.

  • Cueto, Francisco J.
  • Sancho, David
Dendritic cells (DCs) prime anti-tumor T cell responses in tumor-draining lymph nodes and can restimulate T effector responses in the tumor site. Thus, in addition to unleashing T cell effector activity, current immunotherapies should be directed to boost DC function. Herein, we review the potential function of Flt3L as a tool for cancer immunotherapy. Flt3L is a growth factor that acts in Flt3-expressing multipotent progenitors and common lymphoid progenitors. Despite the broad expression of Flt3 in the hematopoietic progenitors, the main effect of the Flt3/Flt3L axis, revealed by the characterization of mice deficient in these genes, is the generation of conventional DCs (cDCs) and plasmacytoid DCs (pDCs). However, Flt3 signaling through PI3K and mTOR may also affect the function of mature DCs. We recapitulate the use of Flt3L in preclinical studies either as a single agent or in combination with other cancer therapies. We also analyze the use of Flt3L in clinical trials. The strong correlation between type 1 cDC (cDC1) infiltration of human cancers with overall survival in many cancer types suggests the potential use of Flt3L to boost expansion of this DC subset. However, this may need the combination of Flt3L with other immunomodulatory agents to boost cancer immunotherapy.
Repisalud
Publicación Artículo científico (JournalArticle)

Genomic instability in the naturally and prematurely aged myocardium.

  • De Majo, Federica
  • Martens, Leonie
  • Hegenbarth, Jana-Charlotte
  • Rühle, Frank
  • Hamczyk, Magda R
  • Nevado, Rosa M
  • Andres, Vicente
  • Hilbold, Erika
  • Bär, Christian
  • Thum, Thomas
  • de Boer, Martine
  • Duncker, Dirk J
  • Schroen, Blanche
  • Armand, Anne-Sophie
  • Stoll, Monika
  • De Windt, Leon J
Genomic instability, the unresolved accumulation of DNA variants, is hypothesized as one of the contributors to the natural aging process. We assessed the frequency of unresolved DNA damage reaching the transcriptome of the murine myocardium during the course of natural aging and in hearts from four distinct mouse models of premature aging with established aging-related cardiac dysfunctions. RNA sequencing and variant calling based on total RNA sequencing was compared between hearts from naturally aging mice, mice with cardiomyocyte-specific deficiency of Ercc1, a component of the DNA repair machinery, mice with reduced mitochondrial antioxidant capacity, Tert-deficient mice with reduced telomere length, and a mouse model of human Hutchinson-Gilford progeria syndrome (HGPS). Our results demonstrate that no enrichment in variants is evident in the naturally aging murine hearts until 2 y of age from the HGPS mouse model or mice with reduced telomere lengths. In contrast, a dramatic accumulation of variants was evident in Ercc1 cardiomyocyte-specific knockout mice with deficient DNA repair machinery, in mice with reduced mitochondrial antioxidant capacity, and in the intestine, liver, and lung of naturally aging mice. Our data demonstrate that genomic instability does not evidently contribute to naturally aging of the mouse heart in contrast to other organs and support the contention that the endogenous DNA repair machinery is remarkably active to maintain genomic integrity in cardiac cells throughout life.
Repisalud
Publicación Artículo científico (JournalArticle)

Extracellular Tuning of Mitochondrial Respiration Leads to Aortic Aneurysm.

  • Oller, Jorge
  • Gabandé-Rodríguez, Enrique
  • Ruiz-Rodríguez, María Jesús
  • Desdín-Micó, Gabriela
  • Aranda, Juan Francisco
  • Rodrigues-Diez, Raquel
  • Ballesteros-Martínez, Constanza
  • Blanco, Eva María
  • Roldan-Montero, Raquel
  • Acuña, Pedro
  • Forteza Gil, Alberto
  • Martín-López, Carlos E
  • Nistal, J Francisco
  • Lino Cardenas, Christian L
  • Lindsay, Mark Evan
  • Martín-Ventura, José Luís
  • Briones, Ana M
  • Redondo, Juan Miguel
  • Mittelbrunn, María
Marfan syndrome (MFS) is an autosomal dominant disorder of the connective tissue caused by mutations in the FBN1 (fibrillin-1) gene encoding a large glycoprotein in the extracellular matrix called fibrillin-1. The major complication of this connective disorder is the risk to develop thoracic aortic aneurysm. To date, no effective pharmacologic therapies have been identified for the management of thoracic aortic disease and the only options capable of preventing aneurysm rupture are endovascular repair or open surgery. Here, we have studied the role of mitochondrial dysfunction in the progression of thoracic aortic aneurysm and mitochondrial boosting strategies as a potential treatment to managing aortic aneurysms. Combining transcriptomics and metabolic analysis of aortas from an MFS mouse model (Fbn1c1039g/+) and MFS patients, we have identified mitochondrial dysfunction alongside with mtDNA depletion as a new hallmark of aortic aneurysm disease in MFS. To demonstrate the importance of mitochondrial decline in the development of aneurysms, we generated a conditional mouse model with mitochondrial dysfunction specifically in vascular smooth muscle cells (VSMC) by conditional depleting Tfam (mitochondrial transcription factor A; Myh11-CreERT2Tfamflox/flox mice). We used a mouse model of MFS to test for drugs that can revert aortic disease by enhancing Tfam levels and mitochondrial respiration. The main canonical pathways highlighted in the transcriptomic analysis in aortas from Fbn1c1039g/+ mice were those related to metabolic function, such as mitochondrial dysfunction. Mitochondrial complexes, whose transcription depends on Tfam and mitochondrial DNA content, were reduced in aortas from young Fbn1c1039g/+ mice. In vitro experiments in Fbn1-silenced VSMCs presented increased lactate production and decreased oxygen consumption. Similar results were found in MFS patients. VSMCs seeded in matrices produced by Fbn1-deficient VSMCs undergo mitochondrial dysfunction. Conditional Tfam-deficient VSMC mice lose their contractile capacity, showed aortic aneurysms, and died prematurely. Restoring mitochondrial metabolism with the NAD precursor nicotinamide riboside rapidly reverses aortic aneurysm in Fbn1c1039g/+ mice. Mitochondrial function of VSMCs is controlled by the extracellular matrix and drives the development of aortic aneurysm in Marfan syndrome. Targeting vascular metabolism is a new available therapeutic strategy for managing aortic aneurysms associated with genetic disorders.
Repisalud
Publicación Artículo científico (JournalArticle)

Bone Marrow Mesenchymal Stem Cells Support Acute Myeloid Leukemia Bioenergetics and Enhance Antioxidant Defense and Escape from Chemotherapy.

  • Forte, Dorian
  • Garcia-Fernandez, Maria
  • Sanchez-Aguilera, Abel
  • Stavropoulou, Vaia
  • Fielding, Claire
  • Martin-Perez, Daniel
  • Lopez, Juan Antonio
  • Costa, Ana S H
  • Tronci, Laura
  • Nikitopoulou, Efterpi
  • Barber, Michael
  • Gallipoli, Paolo
  • Marando, Ludovica
  • Fernandez de Castillejo, Carlos Lopez
  • Tzankov, Alexandar
  • Dietmann, Sabine
  • Cavo, Michele
  • Catani, Lucia
  • Curti, Antonio
  • Vazquez, Jesus
  • Frezza, Christian
  • Huntly, Brian J
  • Schwaller, Juerg
  • Mendez-Ferrer, Simon
Like normal hematopoietic stem cells, leukemic stem cells depend on their bone marrow (BM) microenvironment for survival, but the underlying mechanisms remain largely unknown. We have studied the contribution of nestin+ BM mesenchymal stem cells (BMSCs) to MLL-AF9-driven acute myeloid leukemia (AML) development and chemoresistance in vivo. Unlike bulk stroma, nestin+ BMSC numbers are not reduced in AML, but their function changes to support AML cells, at the expense of non-mutated hematopoietic stem cells (HSCs). Nestin+ cell depletion delays leukemogenesis in primary AML mice and selectively decreases AML, but not normal, cells in chimeric mice. Nestin+ BMSCs support survival and chemotherapy relapse of AML through increased oxidative phosphorylation, tricarboxylic acid (TCA) cycle activity, and glutathione (GSH)-mediated antioxidant defense. Therefore, AML cells co-opt energy sources and antioxidant defense mechanisms from BMSCs to survive chemotherapy.
Repisalud
Publicación Artículo científico (JournalArticle)

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.

  • Zhu, Lucía
  • Retana, Diana
  • García-Gómez, Pedro
  • Álvaro-Espinosa, Laura
  • Priego, Neibla
  • Masmudi-Martín, Mariam
  • Yebra, Natalia
  • Miarka, Lauritz
  • Hernández-Encinas, Elena
  • Blanco-Aparicio, Carmen
  • Martínez, Sonia
  • Sobrino, Cecilia
  • Ajenjo, Nuria
  • Artiga, Maria-Jesus
  • Ortega-Paino, Eva
  • Torres-Ruiz, Raúl
  • Rodríguez-Perales, Sandra
  • Soffietti, Riccardo
  • Bertero, Luca
  • Cassoni, Paola
  • Weiss, Tobias
  • Muñoz, Javier
  • Sepúlveda, Juan Manuel
  • González-León, Pedro
  • Jiménez-Roldán, Luis
  • Moreno, Luis Miguel
  • Esteban, Olga
  • Pérez-Núñez, Ángel
  • Hernández-Laín, Aurelio
  • Toldos, Oscar
  • Ruano, Yolanda
  • Alcázar, Lucía
  • Blasco, Guillermo
  • Fernández-Alén, José
  • Caleiras, Eduardo
  • Lafarga, Miguel
  • Megías, Diego
  • Graña-Castro, Osvaldo
  • Nör, Carolina
  • Taylor, Michael D
  • Young, Leonie S
  • Varešlija, Damir
  • Cosgrove, Nicola
  • Couch, Fergus J
  • Cussó, Lorena
  • Desco, Manuel
  • Mouron, Silvana
  • Quintela Fandino, Miguel Angel
  • Weller, Michael
  • Pastor Fernandez, Joaquin
  • Valiente, Manuel
  • Zhu, Lucía
  • Retana, Diana
  • García-Gómez, Pedro
  • Álvaro-Espinosa, Laura
  • Priego, Neibla
  • Masmudi-Martín, Mariam
  • Yebra, Natalia
  • Miarka, Lauritz
  • Hernández-Encinas, Elena
  • Blanco-Aparicio, Carmen
  • Martínez, Sonia
  • Sobrino, Cecilia
  • Ajenjo, Nuria
  • Artiga, Maria-Jesus
  • Ortega-Paino, Eva
  • Torres-Ruiz, Raúl
  • Rodríguez-Perales, Sandra
  • Soffietti, Riccardo
  • Bertero, Luca
  • Cassoni, Paola
  • Weiss, Tobias
  • Muñoz, Javier
  • Sepúlveda, Juan Manuel
  • González-León, Pedro
  • Jiménez-Roldán, Luis
  • Moreno, Luis Miguel
  • Esteban, Olga
  • Pérez-Núñez, Ángel
  • Hernández-Laín, Aurelio
  • Toldos, Oscar
  • Ruano, Yolanda
  • Alcázar, Lucía
  • Blasco, Guillermo
  • Fernández-Alén, José
  • Caleiras, Eduardo
  • Lafarga, Miguel
  • Megías, Diego
  • Graña-Castro, Osvaldo
  • Nör, Carolina
  • Taylor, Michael D
  • Young, Leonie S
  • Varešlija, Damir
  • Cosgrove, Nicola
  • Couch, Fergus J
  • Cussó, Lorena
  • Desco, Manuel
  • Mouron, Silvana
  • Weller, Michael
We report a medium-throughput drug-screening platform (METPlatform) based on organotypic cultures that allows to evaluate inhibitors against metastases growing in situ. By applying this approach to the unmet clinical need of brain metastasis, we identified several vulnerabilities. Among them, a blood-brain barrier permeable HSP90 inhibitor showed high potency against mouse and human brain metastases at clinically relevant stages of the disease, including a novel model of local relapse after neurosurgery. Furthermore, in situ proteomic analysis applied to metastases treated with the chaperone inhibitor uncovered a novel molecular program in brain metastasis, which includes biomarkers of poor prognosis and actionable mechanisms of resistance. Our work validates METPlatform as a potent resource for metastasis research integrating drug-screening and unbiased omic approaches that is compatible with human samples. Thus, this clinically relevant strategy is aimed to personalize the management of metastatic disease in the brain and elsewhere.
Repisalud
Publicación Artículo científico (JournalArticle)

Folding for the Immune Synapse: CCT Chaperonin and the Cytoskeleton.

  • Martin-Cofreces, Noa B.
  • Valpuesta, Jose Maria
  • Sanchez-Madrid, Francisco
Lymphocytes rearrange their shape, membrane receptors and organelles during cognate contacts with antigen-presenting cells (APCs). Activation of T cells by APCs through pMHC-TCR/CD3 interaction (peptide-major histocompatibility complex-T cell receptor/CD3 complexes) involves different steps that lead to the reorganization of the cytoskeleton and organelles and, eventually, activation of nuclear factors allowing transcription and ultimately, replication and cell division. Both the positioning of the lymphocyte centrosome in close proximity to the APC and the nucleation of a dense microtubule network beneath the plasma membrane from the centrosome support the T cell's intracellular polarity. Signaling from the TCR is facilitated by this traffic, which constitutes an important pathway for regulation of T cell activation. The coordinated enrichment upon T cell stimulation of the chaperonin CCT (chaperonin-containing tailless complex polypeptide 1; also termed TRiC) and tubulins at the centrosome area support polarized tubulin polymerization and T cell activation. The proteasome is also enriched in the centrosome of activated T cells, providing a mechanism to balance local protein synthesis and degradation. CCT assists the folding of proteins coming from de novo synthesis, therefore favoring mRNA translation. The functional role of this chaperonin in regulating cytoskeletal composition and dynamics at the immune synapse is discussed.
Repisalud
Publicación Artículo científico (JournalArticle)

Stress-triggered hematopoietic stem cell proliferation relies on PrimPol-mediated repriming.

  • Jacobs, Kurt
  • Doerdelmann, Cyril
  • Krietsch, Jana
  • González-Acosta, Daniel
  • Mathis, Nicolas
  • Kushinsky, Saul
  • Guarino, Estrella
  • Gómez-Escolar, Carmen
  • Martinez, Dolores
  • Schmid, Jonas A
  • Leary, Peter J
  • Freire, Raimundo
  • Ramiro, Almudena R
  • Eischen, Christine M
  • Mendez, Juan
  • Lopes, Massimo
Stem cell division is linked to tumorigenesis by yet-elusive mechanisms. The hematopoietic system reacts to stress by triggering hematopoietic stem and progenitor cell (HSPC) proliferation, which can be accompanied by chromosomal breakage in activated hematopoietic stem cells (HSCs). However, whether these lesions persist in their downstream progeny and induce a canonical DNA damage response (DDR) remains unclear. Inducing HSPC proliferation by simulated viral infection, we report that the associated DNA damage is restricted to HSCs and that proliferating HSCs rewire their DDR upon endogenous and clastogen-induced damage. Combining transcriptomics, single-cell and single-molecule assays on murine bone marrow cells, we found accelerated fork progression in stimulated HSPCs, reflecting engagement of PrimPol-dependent repriming, at the expense of replication fork reversal. Ultimately, competitive bone marrow transplantation revealed the requirement of PrimPol for efficient HSC amplification and bone marrow reconstitution. Hence, fine-tuning replication fork plasticity is essential to support stem cell functionality upon proliferation stimuli.
Repisalud
Publicación Artículo científico (JournalArticle)

3-deazaadenosine (3DA) alleviates senescence to promote cellular fitness and cell therapy efficiency in mice.

  • Guerrero, Ana
  • Innes, Andrew J
  • Roux, Pierre-François
  • Buisman, Sonja C
  • Jung, Johannes
  • Ortet, Laura
  • Moiseeva, Victoria
  • Wagner, Verena
  • Robinson, Lucas
  • Ausema, Albertina
  • Potapova, Anna
  • Perdiguero, Eusebio
  • Weersing, Ellen
  • Aarts, Marieke
  • Martin, Nadine
  • Wuestefeld, Torsten
  • Muñoz-Cánoves, Pura
  • de Haan, Gerald
  • Bischof, Oliver
  • Gil, Jesús
Cellular senescence is a stable type of cell cycle arrest triggered by different stresses. As such, senescence drives age-related diseases and curbs cellular replicative potential. Here, we show that 3-deazaadenosine (3DA), an S-adenosyl homocysteinase (AHCY) inhibitor, alleviates replicative and oncogene-induced senescence. 3DA-treated senescent cells showed reduced global Histone H3 Lysine 36 trimethylation (H3K36me3), an epigenetic modification that marks the bodies of actively transcribed genes. By integrating transcriptome and epigenome data, we demonstrate that 3DA treatment affects key factors of the senescence transcriptional program. Remarkably, 3DA treatment alleviated senescence and increased the proliferative and regenerative potential of muscle stem cells from very old mice in vitro and in vivo. Moreover, ex vivo 3DA treatment was sufficient to enhance the engraftment of human umbilical cord blood (UCB) cells in immunocompromised mice. Together, our results identify 3DA as a promising drug enhancing the efficiency of cellular therapies by restraining senescence.
Repisalud
Publicación Artículo científico (JournalArticle)

Mitochondrial response to fever boosts T1-driven inflammatory responses.

  • Dunphy, Gillian
  • Sancho, David
Increased body temperature, both locally and systemically, is a key feature of the inflammatory response. Heat is associated with increased blood flow to affected areas and increased immune infiltrate, yet increased temperature has also been described to have direct effects on immune cell function. In a recent study, Heintzman, et al investigated the effect of febrile temperature (39 °C) on T cell function. They describe increased T1 function and fitness accompanied by a decrease in regulatory T cell suppressive function. These findings add another important consequence to our understanding of fever responses.
Repisalud
Publicación Artículo científico (JournalArticle)

Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study.

  • Cortes-Canteli, Marta
  • Gispert, Juan Domingo
  • Salvadó, Gemma
  • Toribio-Fernandez, Raquel
  • Tristão-Pereira, Catarina
  • Falcon, Carles
  • Oliva, Belen
  • Mendiguren, Jose M
  • Fernandez-Friera, Leticia
  • Sanz, Javier
  • Garcia-Ruiz, Jose M
  • Fernandez-Ortiz, Antonio
  • Sanchez-Gonzalez, Javier
  • Ibáñez, Borja
  • Molinuevo, José Luis
  • Fuster, Valentin
Atherosclerosis has been linked to cognitive decline in late life; however, the impact of cardiovascular risk factors (CVRFs) and subclinical atherosclerosis on brain metabolism at earlier stages remains unexplored. This study sought to determine the association between brain metabolism, subclinical atherosclerosis, and CVRFs in middle-aged asymptomatic individuals. This study included 547 asymptomatic middle-aged participants (50 ± 4 years, 82% men) from the PESA (Progression of Early Subclinical Atherosclerosis) study with evidence of subclinical atherosclerosis. Participants underwent 18F-fluorodeoxyglucose (FDG)-positron emission tomography. Global brain FDG uptake and voxel-wise analyses were used to evaluate the associations of cerebral metabolism with CVRFs and atherosclerotic plaque burden in carotids and femorals assessed by 3-dimensional vascular ultrasound. Global FDG uptake showed an inverse correlation with 30-year Framingham Risk Score (FRS) (β = -0.15, p < 0.001). This association was mainly driven by the presence of hypertension (d = 0.36, p < 0.001). Carotid plaque burden was inversely associated with global brain FDG uptake (β = -0.16, p < 0.001), even after adjusting for 30-year FRS. Voxel-wise approaches revealed that the brain areas most strongly affected by hypometabolism in association with 30-year FRS, hypertension, and carotid plaque burden were parietotemporal regions (angular, supramarginal, and inferior/middle temporal gyri) and the cingulate gyrus. In asymptomatic middle-aged individuals, cardiovascular risk is associated with brain hypometabolism, with hypertension being the modifiable CVRF showing the strongest association. Subclinical carotid plaque burden is also linked to reduced brain metabolism independently of CVRFs. Cerebral areas showing hypometabolism include those known to be affected in dementia. These data reinforce the need to control CVRFs early in life in order to potentially reduce the brain's midlife vulnerability to future cognitive dysfunction.
Repisalud
Publicación Artículo científico (JournalArticle)

T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.

  • Céspedes, Pablo F
  • Jainarayanan, Ashwin
  • Fernández-Messina, Lola
  • Valvo, Salvatore
  • Saliba, David G
  • Kurz, Elke
  • Kvalvaag, Audun
  • Chen, Lina
  • Ganskow, Charity
  • Colin-York, Huw
  • Fritzsche, Marco
  • Peng, Yanchun
  • Dong, Tao
  • Johnson, Errin
  • Siller-Farfán, Jesús A
  • Dushek, Omer
  • Sezgin, Erdinc
  • Peacock, Ben
  • Law, Alice
  • Aubert, Dimitri
  • Engledow, Simon
  • Attar, Moustafa
  • Hester, Svenja
  • Fischer, Roman
  • Sánchez-Madrid, Francisco
  • Dustin, Michael L
The immunological synapse is a molecular hub that facilitates the delivery of three activation signals, namely antigen, costimulation/corepression and cytokines, from antigen-presenting cells (APC) to T cells. T cells release a fourth class of signaling entities, trans-synaptic vesicles (tSV), to mediate bidirectional communication. Here we present bead-supported lipid bilayers (BSLB) as versatile synthetic APCs to capture, characterize and advance the understanding of tSV biogenesis. Specifically, the integration of juxtacrine signals, such as CD40 and antigen, results in the adaptive tailoring and release of tSV, which differ in size, yields and immune receptor cargo compared with steadily released extracellular vesicles (EVs). Focusing on CD40L+ tSV as model effectors, we show that PD-L1 trans-presentation together with TSG101, ADAM10 and CD81 are key in determining CD40L vesicular release. Lastly, we find greater RNA-binding protein and microRNA content in tSV compared with EVs, supporting the specialized role of tSV as intercellular messengers.
Repisalud
Publicación Artículo científico (JournalArticle)

Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse.

  • Heras-Murillo, Ignacio
  • Mañanes, Diego
  • Munné, Pablo
  • Núñez, Vanessa
  • Herrera, Jessica
  • Catalá-Montoro, Mauro
  • Alvarez, Maite
  • Del Pozo, Miguel A
  • Melero, Ignacio
  • Wculek, Stefanie K
  • Sancho, David
The potential of dendritic cell (DC) vaccination against cancer is not fully achieved. Little is known about the precise nature of the anti-cancer immune response triggered by different natural DC subsets and their relevance in preventing postsurgical tumor recurrence. Here, we use mouse splenic conventional DC1s (cDC1s) or cDC2s pulsed with tumor cell lysates to generate DC vaccines. cDC1-based vaccination induces a stronger effector and memory CD4 and CD8 anti-tumor T cell response, leading to a better control of tumors treated either therapeutically or prophylactically. Using an experimental model of tumor relapse, we show that adjuvant or neoadjuvant cDC1 vaccination improves anti-tumor immune memory, particularly by increasing the infiltrates of CD4 tissue resident memory (Trm) and CD8 memory T cells. This translates into complete prevention of tumor relapses. Moreover, elevated abundance of cDC1s positively correlates with CD4 Trm presence, and both associate with enhanced survival in human breast cancer and melanoma. Our findings suggest that cDC1-based vaccination excels at immune memory induction and prevention of cancer recurrence.
Repisalud
Publicación Artículo científico (JournalArticle)

Hepatic nutrient and hormone signaling to mTORC1 instructs the postnatal metabolic zonation of the liver.

  • Plata-Gómez, Ana Belén
  • de Prado-Rivas, Lucía
  • Sanz, Alba
  • Deleyto-Seldas, Nerea
  • García, Fernando
  • de la Calle Arregui, Celia
  • Silva, Camila
  • Caleiras, Eduardo
  • Graña-Castro, Osvaldo
  • Piñeiro-Yáñez, Elena
  • Krebs, Joseph
  • Leiva-Vega, Luis
  • Muñoz, Javier
  • Jain, Ajay
  • Sabio, Guadalupe
  • Efeyan, Alejo
The metabolic functions of the liver are spatially organized in a phenomenon called zonation, linked to the differential exposure of portal and central hepatocytes to nutrient-rich blood. The mTORC1 signaling pathway controls cellular metabolism in response to nutrients and insulin fluctuations. Here we show that simultaneous genetic activation of nutrient and hormone signaling to mTORC1 in hepatocytes results in impaired establishment of postnatal metabolic and zonal identity of hepatocytes. Mutant hepatocytes fail to upregulate postnatally the expression of Frizzled receptors 1 and 8, and show reduced Wnt/β-catenin activation. This defect, alongside diminished paracrine Wnt2 ligand expression by endothelial cells, underlies impaired postnatal maturation. Impaired zonation is recapitulated in a model of constant supply of nutrients by parenteral nutrition to piglets. Our work shows the role of hepatocyte sensing of fluctuations in nutrients and hormones for triggering a latent metabolic zonation program.
Repisalud
Publicación Artículo científico (JournalArticle)

Dendritic cell phagosomes recruit GRASP55 for export of antigen-loaded MHC molecules.

  • Cebrian, Ignacio
  • Dinamarca, Sofía
  • Pena Rodríguez, María Jesús
  • Priego, Elena
  • Brouwers, Nathalie
  • Barends, Martina
  • Brunnberg, Jamina
  • Tampé, Robert
  • Blanchard, Nicolas
  • Sancho, David
  • Malhotra, Vivek
Dendritic cells (DCs) present exogenous antigens via major histocompatibility complex class I (MHC-I) and MHC class II (MHC-II) molecules, activating CD8 and CD4 T cells. A critical but poorly understood step in this process is the trafficking of peptide-loaded MHC molecules from the endocytic system to the cell surface. In this study, we demonstrate that the Golgi reassembly-stacking protein of 55 kDa (GRASP55), which has been shown to have no role in stacking, is essential for antigen presentation. Using soluble, bead-coated, and bacterial-bound antigens, we found significantly impaired exogenous antigen presentation in GRASP55-deficient bone-marrow-derived DCs (BMDCs). Notably, GRASP55 was recruited to late phagosomes, and our data suggest that it is crucial for sorting MHC-I and MHC-II molecules, facilitating their trafficking to the plasma membrane. Our findings highlight the vital role of GRASP55 in the intracellular transport of MHC molecules bound to their respective peptides during exogenous antigen presentation.
Repisalud
Publicación Artículo científico (JournalArticle)

β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial.

  • García-Álvarez, Ana
  • Blanco, Isabel
  • García-Lunar, Inés
  • Jordà, Paloma
  • Rodriguez-Arias, Juan J
  • Fernández-Friera, Leticia
  • Zegri, Isabel
  • Nuche, Jorge
  • Gomez-Bueno, Manuel
  • Prat, Susanna
  • Pujadas, Sandra
  • Sole-Gonzalez, Eduard
  • Garcia-Cossio, Maria D
  • Rivas, Mercedes
  • Torrecilla, Estefanía
  • Pereda, Daniel
  • Sanchez, Javier
  • García-Pavía, Pablo
  • Segovia-Cubero, Javier
  • Delgado, Juan F
  • Mirabet, Sonia
  • Fuster, Valentín
  • Barberá, Joan A
  • Ibáñez, Borja
AIMS Pulmonary hypertension (PH) associated with left heart disease is an increasingly prevalent problem, orphan of targeted therapies, and related to a poor prognosis, particularly when pre- and post-capillary PH combine. The current study aimed to determine whether treatment with the selective β3 adrenoreceptor agonist mirabegron improves outcomes in patients with combined pre- and post-capillary PH (CpcPH). METHODS AND RESULTS The β3 Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure (SPHERE-HF) trial is a multicentre, randomized, parallel, placebo-controlled clinical trial that enrolled stable patients with CpcPH associated with symptomatic heart failure. A total of 80 patients were assigned to receive mirabegron (50 mg daily, titrated till 200 mg daily, n = 39) or placebo (n = 41) for 16 weeks. Of them, 66 patients successfully completed the study protocol and were valid for the main analysis. The primary endpoint was the change in pulmonary vascular resistance (PVR) on right heart catheterization. Secondary outcomes included the change in right ventricular (RV) ejection fraction by cardiac magnetic resonance or computed tomography, other haemodynamic variables, functional class, and quality of life. The trial was negative for the primary outcome (placebo-corrected mean difference of 0.62 Wood units, 95% confidence interval [CI] -0.38, 1.61, p = 0.218). Patients receiving mirabegron presented a significant improvement in RV ejection fraction as compared to placebo (placebo-corrected mean difference of 3.0%, 95% CI 0.4, 5.7%, p = 0.026), without significant differences in other pre-specified secondary outcomes. CONCLUSIONS SPHERE-HF is the first clinical trial to assess the potential benefit of β3 adrenergic agonists in PH. The trial was negative since mirabegron did not reduce PVR, the primary endpoint, in patients with CpcPH. On pre-specified secondary outcomes, a significant improvement in RV ejection fraction assessed by advanced cardiac imaging was found, without differences in functional class or quality of life.
Repisalud
Publicación Artículo científico (JournalArticle)

The central clock suffices to drive the majority of circulatory metabolic rhythms.

  • Petrus, Paul
  • Smith, Jacob G
  • Koronowski, Kevin B
  • Chen, Siwei
  • Sato, Tomoki
  • Greco, Carolina M
  • Mortimer, Thomas
  • Welz, Patrick-Simon
  • Zinna, Valentina M
  • Shimaji, Kohei
  • Cervantes, Marlene
  • Punzo, Daniela
  • Baldi, Pierre
  • Muñoz-Cánoves, Pura
  • Sassone-Corsi, Paolo
  • Benitah, Salvador Aznar
Life on Earth anticipates recurring 24-hour environmental cycles via genetically encoded molecular clocks active in all mammalian organs. Communication between these clocks controls circadian homeostasis. Intertissue communication is mediated, in part, by temporal coordination of metabolism. Here, we characterize the extent to which clocks in different organs control systemic metabolic rhythms, an area that remains largely unexplored. We analyzed the metabolome of serum from mice with tissue-specific expression of the clock gene Bmal1. Having functional hepatic and muscle clocks can only drive a minority (13%) of systemic metabolic rhythms. Conversely, limiting Bmal1 expression to the central pacemaker in the brain restores rhythms to 57% of circulatory metabolites. Rhythmic feeding imposed on clockless mice resulted in a similar rescue, indicating that the central clock mainly regulates metabolic rhythms via behavior. These findings explicate the circadian communication between tissues and highlight the importance of the central clock in governing those signals.
Repisalud
Publicación Artículo científico (JournalArticle)

Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.

  • da Silva Lima, Natália
  • Fondevila, Marcos F
  • Nóvoa, Eva
  • Buqué, Xabier
  • Mercado-Gómez, Maria
  • Gallet, Sarah
  • González-Rellan, Maria J
  • Fernandez, Uxia
  • Loyens, Anne
  • Garcia-Vence, Maria
  • Chantada-Vazquez, Maria Del Pilar
  • Bravo, Susana-Belén
  • Marañon, Patricia
  • Senra, Ana
  • Escudero, Adriana
  • Leiva, Magdalena
  • Guallar, Diana
  • Fidalgo, Miguel
  • Gomes, Pedro
  • Claret, Marc
  • Sabio, Guadalupe
  • Varela-Rey, Marta
  • Delgado, Teresa C
  • Montero-Vallejo, Rocio
  • Ampuero, Javier
  • López, Miguel
  • Diéguez, Carlos
  • Herrero, Laura
  • Serra, Dolors
  • Schwaninger, Markus
  • Prevot, Vincent
  • Gallego-Duran, Rocio
  • Romero-Gomez, Manuel
  • Iruzubieta, Paula
  • Crespo, Javier
  • Martinez-Chantar, Maria L
  • Garcia-Monzon, Carmelo
  • Gonzalez-Rodriguez, Agueda
  • Aspichueta, Patricia
  • Nogueiras, Ruben
BACKGROUND & AIMS: Autophagy-related gene 3 (ATG3) is an enzyme mainly known for its actions in the LC3 lipidation process, which is essential for autophagy. Whether ATG3 plays a role in lipid metabolism or contributes to non-alcoholic fatty liver disease (NAFLD) remains unknown. METHODS: By performing proteomic analysis on livers from mice with genetic manipulation of hepatic p63, a regulator of fatty acid metabolism, we identified ATG3 as a new target downstream of p63. ATG3 was evaluated in liver samples from patients with NAFLD. Further, genetic manipulation of ATG3 was performed in human hepatocyte cell lines, primary hepatocytes and in the livers of mice. RESULTS: ATG3 expression is induced in the liver of animal models and patients with NAFLD (both steatosis and non-alcoholic steatohepatitis) compared with those without liver disease. Moreover, genetic knockdown of ATG3 in mice and human hepatocytes ameliorates p63- and diet-induced steatosis, while its overexpression increases the lipid load in hepatocytes. The inhibition of hepatic ATG3 improves fatty acid metabolism by reducing c-Jun N-terminal protein kinase 1 (JNK1), which increases sirtuin 1 (SIRT1), carnitine palmitoyltransferase 1a (CPT1a), and mitochondrial function. Hepatic knockdown of SIRT1 and CPT1a blunts the effects of ATG3 on mitochondrial activity. Unexpectedly, these effects are independent of an autophagic action. CONCLUSIONS: Collectively, these findings indicate that ATG3 is a novel protein implicated in the development of steatosis. LAY SUMMARY: We show that autophagy-related gene 3 (ATG3) contributes to the progression of non-alcoholic fatty liver disease in humans and mice. Hepatic knockdown of ATG3 ameliorates the development of NAFLD by stimulating mitochondrial function. Thus, ATG3 is an important factor implicated in steatosis.
Repisalud
Publicación Artículo científico (JournalArticle)

The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study.

  • Cumplido-Mayoral, Irene
  • Brugulat-Serrat, Anna
  • Sánchez-Benavides, Gonzalo
  • González-Escalante, Armand
  • Anastasi, Federica
  • Milà-Alomà, Marta
  • López-Martos, David
  • Akinci, Muge
  • Falcón, Carles
  • Shekari, Mahnaz
  • Cacciaglia, Raffaele
  • Arenaza-Urquijo, Eider M
  • Minguillón, Carolina
  • Fauria, Karine
  • Molinuevo, José Luis
  • Suárez-Calvet, Marc
  • Grau-Rivera, Oriol
  • Vilaplana, Verónica
  • Gispert, Juan Domingo
BACKGROUND Neuroimaging-based brain-age delta has been shown to be a mediator linking cardiovascular risk factors to cognitive function. We aimed to assess the mediating role of brain-age delta in the association between modifiable risk factors of dementia and longitudinal cognitive decline in middle-aged and older individuals who are asymptomatic, stratified by Alzheimer's disease pathology. We also explored whether the mediation effect is specific to cognitive domain. METHODS In this cohort study, we included participants from the ALFA+ cohort aged between 45 years and 65 years who were cognitively unimpaired and who had available structural MRI, cerebrospinal fluid β-amyloid (Aβ)42 and Aβ40 measurements obtained within 1 year of each other, modifiable risk factors assessment, and cognitive evaluation over 3 years. Participants were recruited from the Barcelonaβeta Brain Research Center (Barcelona, Spain). Included individuals underwent a first assessment between Oct 25, 2016, and Jan 28, 2020, and a follow-up cognitive assessment 3·28 (SD 0·27) years later. We computed brain-age delta and composites of different cognitive function domains (preclinical Alzheimer's cognitive composite [PACC], attention, executive function, episodic memory, visual processing, and language). We used partial least squares path modelling to explore mediation effects in the associations between modifiable risk factors (including cardiovascular, mental health, mood, metabolic or endocrine history, and alcohol use) and changes in cognitive composites. To assess the role of Alzheimer's disease pathology, we computed separate models for Aβ-negative and Aβ-positive individuals. FINDINGS Of the 419 participants enrolled in ALFA+, 302 met our inclusion criteria, of which 108 participants were classified as Aβ-positive and 194 as Aβ-negative. In Aβ-positive individuals, brain-age delta partially mediated (percent mediation proportion 15·73% [95% CI 14·22-16·66]) the association between modifiable risk factors and decline in overall cognition (across cognitive domains). Brain-age delta fully mediated (mediation proportion 28·03% [26·25-29·21]) the effect of modifiable risk factors on the PACC, wherein increased values for risk factors correlated with an older brain-age delta, and, consequently, an older brain-age delta was linked to greater PACC decline. This effect appears to be primarily driven by memory decline. Mediation was not significant in Aβ-negative individuals (3·52% [0·072-4·17]) on PACC, although path coefficients were not significantly different from those in the Aβ-positive group. INTERPRETATION Our findings suggest that brain-age delta captures the association between modifiable risk factors and longitudinal cognitive decline in middle-aged and older people. In asymptomatic middle-aged and older individuals who are Aβ-positive, the pathology might be the strongest driver of cognitive decline, whereas the effect of risk factors is smaller. Our results highlight the potential of brain-age delta as an objective outcome measure for preventive lifestyle interventions targeting cognitive decline. FUNDING La Caixa Foundation, the TriBEKa Imaging Platform, and the Universities and Research Secretariat of the Catalan Government. TRANSLATION For the Spanish translation of the abstract see Supplementary Materials section.
Repisalud
Publicación Artículo científico (JournalArticle)

Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia.

  • Boncompagni, Gioia
  • Tatangelo, Vanessa
  • Lopresti, Ludovica
  • Ulivieri, Cristina
  • Capitani, Nagaja
  • Tangredi, Carmela
  • Finetti, Francesca
  • Marotta, Giuseppe
  • Frezzato, Federica
  • Visentin, Andrea
  • Ciofini, Sara
  • Gozzetti, Alessandro
  • Bocchia, Monica
  • Calzada-Fraile, Diego
  • Martin Cofreces, Noa B
  • Trentin, Livio
  • Patrussi, Laura
  • Baldari, Cosima T
The tumor microenvironment (TME) plays a central role in the pathogenesis of chronic lymphocytic leukemia (CLL), contributing to disease progression and chemoresistance. Leukemic cells shape the TME into a pro-survival and immunosuppressive niche through contact-dependent and contact-independent interactions with the cellular components of the TME. Immune synapse (IS) formation is defective in CLL. Here we asked whether soluble factors released by CLL cells contribute to their protection from cytotoxic T cell (CTL)-mediated killing by interfering with this process. We found that healthy CTLs cultured in media conditioned by leukemic cells from CLL patients or Eμ-TCL1 mice upregulate the exhaustion marker PD-1 and become unable to form functional ISs and kill target cells. These defects were more pronounced when media were conditioned by leukemic cells lacking p66Shc, a proapoptotic adapter whose deficiency has been implicated in disease aggressiveness both in CLL and in the Eμ-TCL1 mouse model. Multiplex ELISA assays showed that leukemic cells from Eμ-TCL1 mice secrete abnormally elevated amounts of CCL22, CCL24, IL-9 and IL-10, which are further upregulated in the absence of p66Shc. Among these, IL-9 and IL-10 were also overexpressed in leukemic cells from CLL patients, where they inversely correlated with residual p66Shc. Using neutralizing antibodies or the recombinant cytokines we show that IL-9, but not IL-10, mediates both the enhancement in PD-1 expression and the suppression of effector functions in healthy CTLs. Our results demonstrate that IL-9 secreted by leukemic cells negatively modulates the anti-tumor immune abilities of CTLs, highlighting a new suppressive mechanism and a novel potential therapeutical target in CLL.
Repisalud
Publicación Artículo científico (JournalArticle)

Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress.

  • Montaldo, Elisa
  • Lusito, Eleonora
  • Bianchessi, Valentina
  • Caronni, Nicoletta
  • Scala, Serena
  • Basso-Ricci, Luca
  • Cantaffa, Carla
  • Masserdotti, Alice
  • Barilaro, Mattia
  • Barresi, Simona
  • Genua, Marco
  • Vittoria, Francesco Maria
  • Barbiera, Giulia
  • Lazarevic, Dejan
  • Messina, Carlo
  • Xue, Elisabetta
  • Marktel, Sarah
  • Tresoldi, Cristina
  • Milani, Raffaella
  • Ronchi, Paola
  • Gattillo, Salvatore
  • Santoleri, Luca
  • Di Micco, Raffaella
  • Ditadi, Andrea
  • Belfiori, Giulio
  • Aleotti, Francesca
  • Naldini, Matteo Maria
  • Gentner, Bernhard
  • Gardiman, Elisa
  • Tamassia, Nicola
  • Cassatella, Marco Antonio
  • Hidalgo, Andres
  • Kwok, Immanuel
  • Ng, Lai Guan
  • Crippa, Stefano
  • Falconi, Massimo
  • Pettinella, Francesca
  • Scapini, Patrizia
  • Naldini, Luigi
  • Ciceri, Fabio
  • Aiuti, Alessandro
  • Ostuni, Renato
Traditionally viewed as poorly plastic, neutrophils are now recognized as functionally diverse; however, the extent and determinants of neutrophil heterogeneity in humans remain unclear. We performed a comprehensive immunophenotypic and transcriptome analysis, at a bulk and single-cell level, of neutrophils from healthy donors and patients undergoing stress myelopoiesis upon exposure to growth factors, transplantation of hematopoietic stem cells (HSC-T), development of pancreatic cancer and viral infection. We uncover an extreme diversity of human neutrophils in vivo, reflecting the rates of cell mobilization, differentiation and exposure to environmental signals. Integrated control of developmental and inducible transcriptional programs linked flexible granulopoietic outputs with elicitation of stimulus-specific functional responses. In this context, we detected an acute interferon (IFN) response in the blood of patients receiving HSC-T that was mirrored by marked upregulation of IFN-stimulated genes in neutrophils but not in monocytes. Systematic characterization of human neutrophil plasticity may uncover clinically relevant biomarkers and support the development of diagnostic and therapeutic tools.
Repisalud
Publicación Artículo científico (JournalArticle)

CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.

  • Cibrian, Danay
  • Saiz, María Laura
  • de la Fuente, Hortensia
  • Sánchez-Díaz, Raquel
  • Moreno-Gonzalo, Olga
  • Jorge, Inmaculada
  • Ferrarini, Alessia
  • Vázquez, Jesús
  • Punzón, Carmen
  • Fresno, Manuel
  • Vicente-Manzanares, Miguel
  • Daudén, Esteban
  • Fernández-Salguero, Pedro M
  • Martín, Pilar
  • Sánchez-Madrid, Francisco
The activation marker CD69 is expressed by skin γδ T cells. Here we found that CD69 controlled the aryl hydrocarbon receptor (AhR)-dependent secretion of interleukin 22 (IL-22) by γδ T cells, which contributed to the development of psoriasis induced by IL-23. CD69 associated with the aromatic-amino-acid-transporter complex LAT1-CD98 and regulated its surface expression and uptake of L-tryptophan (L-Trp) and the intracellular quantity of L-Trp-derived activators of AhR. In vivo administration of L-Trp, an inhibitor of AhR or IL-22 abrogated the differences between CD69-deficient mice and wild-type mice in skin inflammation. We also observed LAT1-mediated regulation of AhR activation and IL-22 secretion in circulating Vγ9(+) γδ T cells of psoriatic patients. Thus, CD69 serves as a key mediator of the pathogenesis of psoriasis by controlling LAT1-CD98-mediated metabolic cues.
Repisalud
Publicación Artículo científico (JournalArticle)

Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

  • Rossello, Xavier
  • Raposeiras-Roubin, Sergio
  • Oliva, Belén
  • Sanchez-Cabo, Fatima
  • García-Ruíz, José M
  • Caimari, Francisca
  • Mendiguren, José M
  • Lara-Pezzi, Enrique
  • Bueno, Hector
  • Fernández-Friera, Leticia
  • Fernández-Ortiz, Antonio
  • Sanz, Javier
  • Ibáñez, Borja
  • Fuster, Valentin
Background: The metabolic injury caused by protein glycation, monitored as the level of glycated hemoglobin (HbA1c), is not represented in most risk scores (i.e., Systematic Coronary Risk Estimation or atherosclerotic cardiovascular disease risk scale). Objectives: The purpose of this study was to assess the association between HbA1c and the extent of subclinical atherosclerosis (SA) and to better identify individuals at higher risk of extensive SA using HbA1c on top of key cardiovascular risk factors (CVRFs). Methods: A cohort of 3,973 middle-aged individuals from the PESA (Progression of Early Subclinical Atherosclerosis) study, with no history of cardiovascular disease and with HbA1c in the nondiabetic range, were assessed for the presence and extent of SA by 2-dimensional vascular ultrasound and noncontrast cardiac computed tomography. Results: After adjusting for established CVRFs, HbA1c showed an association with the multiterritorial extent of SA (odds ratio: 1.05, 1.27, 1.27, 1.36, 1.80, 1.87, and 2.47 for HbA1c 4.9% to 5.0%, 5.1% to 5.2%, 5.3% to 5.4%, 5.5% to 5.6%, 5.7% to 5.8%, 5.9% to 6.0%, and 6.1% to 6.4%, respectively; reference HbA1c ≤4.8%; p < 0.001). The association was significant in all pre-diabetes groups and even below the pre-diabetes cut-off (HbA1c 5.5% to 5.6% odds ratio: 1.36 [95% confidence interval: 1.03 to 1.80]; p = 0.033). High HbA1c was associated with an increased risk of SA in low-risk individuals (p < 0.001), but not in moderate-risk individuals (p = 0.335). Relative risk estimations using Systematic Coronary Risk Estimation or atherosclerotic cardiovascular disease predictors confirmed that inclusion of HbA1c modified the risk of multiterritorial SA in most risk categories. Conclusions: Routine use of HbA1c can identify asymptomatic individuals at higher risk of SA on top of traditional CVRFs. Lifestyle interventions and novel antidiabetic medications might be considered to reduce both HbA1c levels and SA in individuals without diabetes.
Repisalud
Publicación Artículo científico (JournalArticle)

Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure.

  • Mora-Ayestarán, Nerea
  • Ochoa, Juan Pablo
  • Gómez-González, Cristina
  • Navarro-Peñalver, Marina
  • Gallego-Delgado, María
  • Larrañaga-Moreira, José M
  • Robles-Mezcua, Ainhoa
  • Basurte-Elorz, María Teresa
  • Rodriguez-Palomares, Jose Fernando
  • Climent-Paya, Vicente
  • Jiménez-Jaímez, Juan
  • Mogollón-Jiménez, Maria Victoria
  • García-Granja, Pablo Elpidio
  • García-Álvarez, Ana
  • Peña-Peña, María Luisa
  • Alvarez Barredo, María
  • Ripoll-Vera, Tomas
  • Palomino-Doza, Julián
  • Bayes-Genis, Antoni
  • Tirón, Coloma
  • Fernández, Ana Isabel
  • Sabater-Molina, María
  • Toranzo, Inés
  • Crespo-Leiro, María G
  • Doncel-Abad, Victoria
  • Lacuey-Lecumberri, Gemma
  • Limeres-Freire, Javier
  • García-Álvarez, Maria I
  • Cabrera-Borrego, Eva
  • Kounka-Ait El Maalem, Zineb
  • Vilches, Silvia
  • González-López, Esther
  • Villacorta, Eduardo
  • García-Pinilla, José M
  • Barriales-Villa, Roberto
  • Gimeno-Blanes, Juan Ramón
  • Garcia-Pavia, Pablo
  • Domínguez, Fernando
Certain genetic forms of dilated cardiomyopathy (DCM) entail a higher arrhythmic risk. It is unknown whether DCM patients with high-risk arrhythmic genotypes also develop more advanced heart failure (AHF) complications. AHF events were studied according to DCM genotype. Clinical data from 1203 genotyped DCM patients were collected from 19 Spanish centres. Patients were classified into high-risk arrhythmic genotypes (LMNA, FLNC, desmosomal genes, PLN, TMEM43, RBM20), TTN, other genes, and genotype negative (Gen-). The primary endpoint was a composite of AHF events (ventricular assist device implantation, heart transplant, and AHF-related mortality). The secondary endpoint was a combination of malignant ventricular arrhythmias (MVA). A DCM-causing variant was identified in a high-risk arrhythmic gene in 185 patients (15.4%), 193 (16.0%) had variants in TTN, 134 (11.1%) in other genes, and 691 (57.4%) were Gen-. After a median follow-up of 5.7 years (interquartile range 2.9-9.1 years), AHF events occurred in 45 (24.3%) patients in the high-risk arrhythmic group, while in 25 (18.7%), 25 (13.0%), and 70 (10.1%) patients with other genotypes, TTN, and Gen-, respectively (hazard ratio 1.85, 95% confidence interval 1.31-2.61 for high-risk arrhythmic genes compared with other groups). MVA occurred in 55 patients (29.7%) (hazard ratio 2.52, 95% confidence interval 1.81-3.51 for high-risk genotypes vs other groups). High-risk arrhythmic genotype was the main independent predictor of AHF in multivariate analysis. High-risk arrhythmic genotype and late gadolinium enhancement were independent predictors of MVA. Patients with high-risk arrhythmic genotypes also experience more AHF events, supporting a differential therapeutic approach in this group of patients beyond sudden death prevention.
Repisalud
Publicación Artículo científico (JournalArticle)

A novel computational model of swine ventricular myocyte reveals new insights into disease mechanisms and therapeutic approaches in Timothy Syndrome

Repisalud
Publicación Artículo científico (JournalArticle)

Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.

  • Ghigo, Alessandra
  • Ameri, Pietro
  • Asnani, Aarti
  • Bertero, Edoardo
  • de Boer, Rudolf A
  • Farmakis, Dimitrios
  • González, Arantxa
  • Heymans, Stephane
  • Ibáñez, Borja
  • López-Fernández, Teresa
  • Lyon, Alexander R
  • Pollesello, Piero
  • Rakisheva, Amina
  • Stellos, Konstantinos
  • Streckfuss-Bömeke, Katrin
  • Tocchetti, Carlo Gabriele
  • Thum, Thomas
  • van der Meer, Peter
  • Van Rooij, Eva
  • Ponikowski, Piotr
  • Metra, Marco
  • Rosano, Giuseppe
  • Van Linthout, Sophie
New anticancer therapies with potential cardiovascular side effects are continuously being introduced into clinical practice, with new and often unexpected toxicities becoming apparent only after clinical introduction. These unknown toxicities should be identified and understood beforehand to better prepare patients and physicians, enabling the implementation of effective treatments. Therefore, there is a crucial need for appropriate preclinical models to understand the biological basis of their cardiotoxicity. This scientific statement summarizes the preclinical models hitherto used, from in vitro two- and three-dimensional human systems to small and large animals, to pinpoint the molecular mechanisms behind the cardiotoxicity of new-generation anticancer therapies, particularly immunotherapies, and to develop potential cardioprotective strategies. Furthermore, it discusses how preclinical models have contributed to the provocative concept of heart failure being potentially tumorigenic and how the discovery of drugs with both anticancer and cardioprotective actions has revealed a common mechanistic basis for heart failure and cancer. Finally, it discusses the existing gaps between preclinical models and clinical observations in patients, how these discrepancies affect regulatory pathways and the drug development process in cardio-oncology and provides recommendations for closing these gaps.
Repisalud
Publicación Tesis doctoral (DoctoralThesis)

Mechanisms involved in quiescent blood vessel homeostasis

  • Fernandez-Chacon, Macarena
Our vascular system is an organized and hierarchical blood vessel network lined by a monolayer of endothelial cells (ECs) that supplies oxygen and nutrients to all tissues and organs in our body. Importantly, they are not passive conduits for blood flow and they contribute to organ physiology and homeostasis throughout the entire life of the organisms. Therefore, it is not surprising that an imbalance of this vascular network is involved the pathogenesis of many diseases such as cancer, stroke or myocardial infarction. The Notch signalling pathway is a critical regulator in the process of angiogenesis, participating in the tip-stalk specification, arterial-venous differentiation, vessel stabilization and maturation. Importantly, pharmacological compounds targeting distinct members of the Notch signalling pathway have been used in the clinics but their effect on the homeostasis of different types of blood vessels is unknown. In this thesis, we have developed and used a wide range of novel genetic tools, loss-offunction mouse models, imaging, trancriptomic and proteomic approaches to uncover the role of several Notch signalling members in the regulation of organ-specific vascular homeostasis at high cellular and molecular resolution. We found that Dll4/Notch signalling is active in most quiescent endothelium of several organs, such as the heart, lung, liver and brain. However, despite being active in all the mentioned vascular tissues, only in heart and liver vessels it plays an essential role in the maintenance of vascular quiescence by actively repressing EC proliferation. By using comparative transcriptomic and proteomic approaches, we found that Dll4/Notch1 actively supresses the Myc pathway to sustain vascular quiescence in the liver. By analysing a series of Notch signalling mutants, we found that while loss of the ligand Dll4 leads to an intermediate increase in p-ERK levels and cell cycle entry, resulting in EC hyperproliferation; loss of the co-factor Rbpj or the receptor Notch1 induces even higher ERK signalling activity but not EC proliferation. At high p-ERK levels there is an increase in the expression of the cell cycle inhibitor p21, which arrests EC proliferation. These arrested cells have also several features of endothelial senescence. In addition, we observed that the loss of Dll4/Notch signalling in liver ECs, promotes the transient increase in the proliferation of neighboring hepatocytes prior to their own expansion, suggesting the existence of angiocrine factors secreted by ECs after the loss of Notch signalling. Moreover, the effect of Notch on liver endothelial cell proliferation was very heterogenous and zonated. ECs located close to the central veins had a higher proliferation potential compared to the endothelium located in oxygen-rich periportal zones. Using multispectral genetic mosaics, we also identified a rare population of liver ECs that is able to clonally expand more than most of their neighbours, suggesting the existence of liver-resident endothelial progenitor cells. In addition to these studies on the role of Notch in vascular biology, we also used and validated an inducible dual reporter-Cre mouse allele (iSuRe-Cre), which by significantly increasing Cre activity in reporter-expressing cells, it provides certainty that these cells have completely recombined floxed alleles.
Repisalud
Publicación Artículo científico (JournalArticle)

Zebrafish mutants in vegfab can affect endothelial cell proliferation without altering ERK phosphorylation and are phenocopied by loss of PI3K signaling.

  • Lange, Martin
  • Ohnesorge, Nils
  • Hoffmann, Dennis
  • Rocha, Susana F
  • Benedito, Rui
  • Siekmann, Arndt F
The formation of appropriately patterned blood vessel networks requires endothelial cell migration and proliferation. Signaling through the Vascular Endothelial Growth Factor A (VEGFA) pathway is instrumental in coordinating these processes. mRNA splicing generates short (diffusible) and long (extracellular matrix bound) Vegfa isoforms. The differences between these isoforms in controlling cellular functions are not understood. In zebrafish, vegfaa generates short and long isoforms, while vegfab only generates long isoforms. We found that mutations in vegfaa had an impact on endothelial cell (EC) migration and proliferation. Surprisingly, mutations in vegfab more strongly affected EC proliferation in distinct blood vessels, such as intersegmental blood vessels in the zebrafish trunk and central arteries in the head. Analysis of downstream signaling pathways revealed no change in MAPK (ERK) activation, while inhibiting PI3 kinase signaling phenocopied vegfab mutant phenotypes in affected blood vessels. Together, these results suggest that extracellular matrix bound Vegfa might act through PI3K signaling to control EC proliferation in a distinct set of blood vessels during angiogenesis.
Repisalud
Publicación Artículo científico (JournalArticle)

A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan.

  • Ortega-Molina, Ana
  • Lebrero-Fernández, Cristina
  • Sanz, Alba
  • Calvo-Rubio, Miguel
  • Deleyto-Seldas, Nerea
  • de Prado-Rivas, Lucía
  • Plata-Gómez, Ana Belén
  • Fernández-Florido, Elena
  • González-García, Patricia
  • Vivas-García, Yurena
  • Sánchez García, Elena
  • Graña-Castro, Osvaldo
  • Price, Nathan L
  • Aroca-Crevillén, Alejandra
  • Caleiras, Eduardo
  • Monleón, Daniel
  • Borrás, Consuelo
  • Casanova-Acebes, María
  • de Cabo, Rafael
  • Efeyan, Alejo
The mechanistic target of rapamycin complex 1 controls cellular anabolism in response to growth factor signaling and to nutrient sufficiency signaled through the Rag GTPases. Inhibition of mTOR reproducibly extends longevity across eukaryotes. Here we report that mice that endogenously express active mutant variants of RagC exhibit multiple features of parenchymal damage that include senescence, expression of inflammatory molecules, increased myeloid inflammation with extensive features of inflammaging and a ~30% reduction in lifespan. Through bone marrow transplantation experiments, we show that myeloid cells are abnormally activated by signals emanating from dysfunctional RagC-mutant parenchyma, causing neutrophil extravasation that inflicts additional inflammatory damage. Therapeutic suppression of myeloid inflammation in aged RagC-mutant mice attenuates parenchymal damage and extends survival. Together, our findings link mildly increased nutrient signaling to limited lifespan in mammals, and support a two-component process of parenchymal damage and myeloid inflammation that together precipitate a time-dependent organ deterioration that limits longevity.
Repisalud
Publicación Artículo científico (JournalArticle)

The Art of Prescribing β-Blockers After Myocardial Infarction.

Repisalud
Publicación Artículo científico (JournalArticle)

Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes.

  • Culemann, Stephan
  • Knab, Katharina
  • Euler, Maximilien
  • Wegner, Anja
  • Garibagaoglu, Hilal
  • Ackermann, Jochen
  • Fischer, Kim
  • Kienhöfer, Deborah
  • Crainiciuc, Georgiana
  • Hahn, Jonas
  • Grüneboom, Anika
  • Nimmerjahn, Falk
  • Uderhardt, Stefan
  • Hidalgo, Andres
  • Schett, Georg
  • Hoffmann, Markus H
  • Krönke, Gerhard
Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.
Repisalud
Publicación Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response.

  • Rochano-Ortiz, Antonio
  • San Sebastián-Jaraba, Irene
  • Zamora, Carmen
  • Simó, Carolina
  • García-Cañas, Virginia
  • Martínez-Albaladejo, Sacramento
  • Fernández-Gómez, María José
  • Marcos-Ríos, Daniel
  • Martínez-Núñez, Patricia
  • Martín-Lorenzo, Marta
  • Velho, Tiago R
  • Ruíz-Rodríguez, María Jesús
  • Leal-Zafra, Amanda
  • Gabandé-Rodríguez, Enrique
  • Martínez-Martínez, Sara
  • Guala, Andrea
  • Lorenzo, Óscar
  • Blanco-Colio, Luis Miguel
  • Martín-Ventura, José Luís
  • Álvarez-Llamas, Gloria
  • Aldamiz-Echevarría, Gonzalo
  • Teixidó-Tura, Gisela
  • Forteza, Alberto
  • Nistal, Juan Francisco
  • Redondo, Juan Miguel
  • Méndez-Barbero, Nerea
  • Mittelbrunn, María
  • Oller, Jorge
Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology. Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential. Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model. The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin.
Repisalud
Publicación Artículo científico (JournalArticle)

Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology.

  • Mühleder, Severin
  • Fernandez-Chacon, Macarena
  • Garcia-Gonzalez, Irene
  • Benedito, Rui
Therapeutic modulation of vascular cell proliferation and migration is essential for the effective inhibition of angiogenesis in cancer or its induction in cardiovascular disease. The general view is that an increase in vascular growth factor levels or mitogenic stimulation is beneficial for angiogenesis, since it leads to an increase in both endothelial proliferation and sprouting. However, several recent studies showed that an increase in mitogenic stimuli can also lead to the arrest of angiogenesis. This is due to the existence of intrinsic signaling feedback loops and cell cycle checkpoints that work in synchrony to maintain a balance between endothelial proliferation and sprouting. This balance is tightly and effectively regulated during tissue growth and is often deregulated or impaired in disease. Most therapeutic strategies used so far to promote vascular growth simply increase mitogenic stimuli, without taking into account its deleterious effects on this balance and on vascular cells. Here, we review the main findings on the mechanisms controlling physiological vascular sprouting, proliferation, and senescence and how those mechanisms are often deregulated in acquired or congenital cardiovascular disease leading to a diverse range of pathologies. We also discuss alternative approaches to increase the effectiveness of pro-angiogenic therapies in cardiovascular regenerative medicine.
Repisalud
Publicación Artículo científico (JournalArticle)

The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity.

Repisalud
Publicación Artículo científico (JournalArticle)

Metabolism of tissue macrophages in homeostasis and pathology.

  • Wculek, Stefanie K
  • Dunphy, Gillian
  • Heras-Murillo, Ignacio
  • Mastrangelo, Annalaura
  • Sancho, David
Cellular metabolism orchestrates the intricate use of tissue fuels for catabolism and anabolism to generate cellular energy and structural components. The emerging field of immunometabolism highlights the importance of cellular metabolism for the maintenance and activities of immune cells. Macrophages are embryo- or adult bone marrow-derived leukocytes that are key for healthy tissue homeostasis but can also contribute to pathologies such as metabolic syndrome, atherosclerosis, fibrosis or cancer. Macrophage metabolism has largely been studied in vitro. However, different organs contain diverse macrophage populations that specialize in distinct and often tissue-specific functions. This context specificity creates diverging metabolic challenges for tissue macrophage populations to fulfill their homeostatic roles in their particular microenvironment and conditions their response in pathological conditions. Here, we outline current knowledge on the metabolic requirements and adaptations of macrophages located in tissues during homeostasis and selected diseases.
Repisalud
Publicación Artículo científico (JournalArticle)

Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis.

  • Muller, Steven A
  • Peiró-Aventin, Belén
  • Biagioni, Giulia
  • Tini, Giacomo
  • Saturi, Giulia
  • Kronberger, Christina
  • Achten, Anouk
  • Dobner, Stephan
  • Te Rijdt, Wouter P
  • Gasperetti, Alessio
  • Te Riele, Anneline S J M
  • Varrà, Guerino G
  • Ponziani, Alberto
  • Hirsch, Alexander
  • Porcari, Aldostefano
  • van der Meer, Manon G
  • Zampieri, Mattia
  • van der Harst, Pim
  • Kammerlander, Andreas
  • Biagini, Elena
  • van Tintelen, J Peter
  • Barbato, Emanuele
  • Asselbergs, Folkert W
  • Menale, Silvia
  • Gräni, Christoph
  • Merlo, Marco
  • Michels, Michelle
  • Knackstedt, Christian
  • Nitsche, Christian
  • Longhi, Simone
  • Musumeci, Beatrice
  • Cappelli, Francesco
  • Garcia-Pavia, Pablo
  • Oerlemans, Marish I F J
AIMS The 2021 European Society of Cardiology (ESC) screening recommendations for individuals carrying a pathogenic transthyretin amyloidosis variant (ATTRv) are based on expert opinion. We aimed to (i) determine the penetrance of ATTRv cardiomyopathy (ATTRv-CM) at baseline; (ii) examine the value of serial evaluation; and (iii) establish the yield of first-line diagnostic tests (i.e. electrocardiogram, echocardiogram, and laboratory tests) as per 2021 ESC position statement. METHODS AND RESULTS We included 159 relatives (median age 55.6 [43.2-65.9] years, 52% male) at risk for ATTRv-CM from 10 centres. The primary endpoint, ATTRv-CM diagnosis, was defined as the presence of (i) cardiac tracer uptake in bone scintigraphy; or (ii) transthyretin-positive cardiac biopsy. The secondary endpoint was a composite of heart failure (New York Heart Association class ≥II) and pacemaker-requiring conduction disorders. At baseline, 40/159 (25%) relatives were diagnosed with ATTRv-CM. Of those, 20 (50%) met the secondary endpoint. Indication to screen (≤10 years prior to predicted disease onset and absence of extracardiac amyloidosis) had an excellent negative predictive value (97%). Other pre-screening predictors for ATTRv-CM were infrequently identified variants and male sex. Importantly, 13% of relatives with ATTRv-CM did not show any signs of cardiac involvement on first-line diagnostic tests. The yield of serial evaluation (n = 41 relatives; follow-up 3.1 [2.2-5.2] years) at 3-year interval was 9.4%. CONCLUSIONS Screening according to the 2021 ESC position statement performs well in daily clinical practice. Clinicians should adhere to repeating bone scintigraphy after 3 years, as progressing to ATTRv-CM without signs of ATTRv-CM on first-line diagnostic tests or symptoms is common.
Repisalud
Publicación Artículo científico (JournalArticle)

Linking birth experience and perinatal depression symptoms to neuroanatomical changes in hippocampus and amygdala.

  • Ballesteros, Cristina
  • Paternina-Die, María
  • Martínez-García, Magdalena
  • López-Montoya, Gonzalo
  • Noguero, Inés
  • Desco, Manuel
  • Vilarroya, Oscar
  • de Blas, Daniel Martín
  • Carmona, Susana
Childbirth is a life-changing event in a mother's life. While the transition to motherhood has recently been recognized as one of the most neuroplastic periods in adulthood, no study has yet explored whether the hippocampus and amygdala change during the peripartum in relation to childbirth experience and perinatal depression symptoms. In this longitudinal neuroimaging study, we assessed 88 first-time gestational mothers in late pregnancy and early postpartum and 30 nulliparous control women. We used optimized high-resolution MRI scans to quantify volumetric changes in the hippocampus and amygdala, along with their substructures. We found that increases in depression symptoms during the peripartum were positively correlated with changes in the right amygdala. A more challenging birth experience was associated with bilateral increases in hippocampal volume. These findings show that studying the neuroanatomical changes during the transition to motherhood can inform not only about adaptive processes but also about potential vulnerabilities, highlighting the importance of tracking perinatal experiences to enhance women's health.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Cardioprotection strategies for anthracycline cardiotoxicity.

  • Moreno-Arciniegas, Andrea
  • Cádiz, Laura
  • Galán-Arriola, Carlos
  • Clemente-Moragón, Agustín
  • Ibáñez, Borja
Thanks to the fantastic progress in cancer therapy options, there is a growing population of cancer survivors. This success has resulted in a need to focus much effort into improving the quality of life of this population. Cancer and cardiovascular disease share many common risk factors and have an interplay between them, with one condition mechanistically affecting the other and vice versa. Furthermore, widely prescribed cancer therapies have known toxic effects in the cardiovascular system. Anthracyclines are the paradigm of efficacious cancer therapy widely prescribed with a strong cardiotoxic potential. While some cancer therapies cardiovascular toxicities are transient, others are irreversible. There is a growing need to develop cardioprotective therapies that, when used in conjunction with cancer therapies, can prevent cardiovascular toxicity and thus improve long-term quality of life in survivors. The field has three main challenges: (i) identification of the ultimate mechanisms leading to cardiotoxicity to (ii) identify specific therapeutic targets, and (iii) more sensible diagnostic tools to early identify these conditions. In this review we will focus on the cardioprotective strategies tested and under investigation. We will focus this article into anthracycline cardiotoxicity since it is still the agent most widely prescribed, the one with higher toxic effects on the heart, and the most widely studied.
Repisalud
Publicación Artículo científico (JournalArticle)

The impact of type 2 immunity and allergic diseases in atherosclerosis.

  • Fernández-Gallego, Nieves
  • Castillo-González, Raquel
  • Méndez-Barbero, Nerea
  • López-Sanz, Celia
  • Obeso, David
  • Villaseñor, Alma
  • Escribese, María M
  • López-Melgar, Beatriz
  • Salamanca, Jorge
  • Benedicto-Buendía, Amparo
  • Jiménez-Borreguero, Luis Jesús
  • Ibáñez, Borja
  • Sastre, Joaquín
  • Belver, María Teresa
  • Vega, Francisco
  • Blanco, Carlos
  • Barber, Domingo
  • Sánchez-Madrid, Francisco
  • de la Fuente, Hortensia
  • Martin, Pilar
  • Esteban, Vanesa
  • Jiménez-Saiz, Rodrigo
  • Fernández‐Gallego, Nieves
  • Castillo‐González, Raquel
  • Méndez‐Barbero, Nerea
  • López‐Sanz, Celia
  • Escribese, María M.
  • López‐Melgar, Beatriz
  • Benedicto‐Buendía, Amparo
  • Jiménez‐Borreguero, Luis Jesús
  • Sánchez‐Madrid, Francisco
  • Jiménez‐Saiz, Rodrigo
Allergic diseases are allergen-induced immunological disorders characterized by the development of type 2 immunity and IgE responses. The prevalence of allergic diseases has been on the rise alike cardiovascular disease (CVD), which affects arteries of different organs such as the heart, the kidney and the brain. The underlying cause of CVD is often atherosclerosis, a disease distinguished by endothelial dysfunction, fibrofatty material accumulation in the intima of the artery wall, smooth muscle cell proliferation, and Th1 inflammation. The opposed T-cell identity of allergy and atherosclerosis implies an atheroprotective role for Th2 cells by counteracting Th1 responses. Yet, the clinical association between allergic disease and CVD argues against it. Within, we review different phases of allergic pathology, basic immunological mechanisms of atherosclerosis and the clinical association between allergic diseases (particularly asthma, atopic dermatitis, allergic rhinitis and food allergy) and CVD. Then, we discuss putative atherogenic mechanisms of type 2 immunity and allergic inflammation including acute allergic reactions (IgE, IgG1, mast cells, macrophages and allergic mediators such as vasoactive components, growth factors and those derived from the complement, contact and coagulation systems) and late phase inflammation (Th2 cells, eosinophils, type 2 innate-like lymphoid cells, alarmins, IL-4, IL-5, IL-9, IL-13 and IL-17).
Repisalud
Publicación Artículo científico (JournalArticle)

Variation of PEAR1 DNA methylation influences platelet and leukocyte function.

  • Izzi, Benedetta
  • Gianfagna, Francesco
  • Yang, Wen-Yi
  • Cludts, Katrien
  • De Curtis, Amalia
  • Verhamme, Peter
  • Di Castelnuovo, Augusto
  • Cerletti, Chiara
  • Donati, Maria Benedetta
  • de Gaetano, Giovanni
  • Staessen, Jan A
  • Hoylaerts, Marc F
  • Iacoviello, Licia
Platelet-endothelial aggregation receptor 1 (PEAR-1) is a transmembrane receptor involved in platelet activation and megakaryopoiesis whose expression is driven by DNA methylation. PEAR1 variants were associated with differential platelet response to activation and cardiovascular outcomes. We aimed at investigating the link between PEAR1 methylation and platelet and leukocyte function markers in a family-based population. We measured PEAR1 methylation in 605 Moli-family participants with available blood counts, plasma P-selectin and C-reactive protein, whole blood platelet P-selectin, and platelet-leukocyte mixed conjugate measurements. We performed principal component analysis (PCA) to identify groups of highly correlated CpG sites. We used linear mixed regression models (using age, gender, BMI, smoking, alcohol drinking, being a proband for family recruitment, being a member of myocardial infarction (MI) family as fixed effects, and family as a random effect) to evaluate associations between PEAR1 methylation and phenotypes. PEAR1 methylation Factor2, characterized by the previously identified megakaryocyte-specific CpG sites, was inversely associated with platelet-monocyte conjugates, P-selectin, and WBC counts, while positively associated with the platelet distribution width (PDW) and with leukocyte CD11b and L-selectin. Moreover, PEAR1 Factor2 methylation was negatively associated with INFLAscore, a low-grade inflammation score. The latter was partially mediated by the PEAR1 methylation effect on platelet variables. PEAR1 methylation association with WBC measurements and INFLAscore was confirmed in the independent cohort FLEMENGHO. We report a significant link between epigenetic signatures in a platelet functional gene and inflammation-dependent platelet function variability measured in two independent cohorts.
Repisalud
Publicación Reseña (Review)

Context-dependent roles of cellular senescence in normal, aged, and disease states.

  • Moiseeva, Victoria
  • Cisneros, Andrés
  • Cobos, Aina Calls
  • Tarrega, Aida Beà
  • Oñate, Claudia Santos
  • Perdiguero, Eusebio
  • Serrano, Antonio L
  • Muñoz-Cánoves, Pura
Cellular senescence is a state of irreversible cell cycle arrest that often emerges after tissue damage and in age-related diseases. Through the production of a multicomponent secretory phenotype (SASP), senescent cells can impact the regeneration and function of tissues. However, the effects of senescent cells and their SASP are very heterogeneous and depend on the tissue environment and type as well as the duration of injury, the degree of persistence of senescent cells and the organism's age. While the transient presence of senescent cells is widely believed to be beneficial, recent data suggest that it is detrimental for tissue regeneration after acute damage. Furthermore, although senescent cell persistence is typically associated with the progression of age-related chronic degenerative diseases, it now appears to be also necessary for correct tissue function in the elderly. Here, we discuss what is currently known about the roles of senescent cells and their SASP in tissue regeneration in ageing and age-related diseases, highlighting their (negative and/or positive) contributions. We provide insight for future research, including the possibility of senolytic-based therapies and cellular reprogramming, with aims ranging from enhancing tissue repair to extending a healthy lifespan.
Repisalud
Publicación Artículo científico (JournalArticle)

Ischemic postconditioning fails to reduce infarct size in pig models of intermediate and prolonged ischemia

  • Nuche, Jorge
  • Galán-Arriola, Carlos
  • Fernández-Jiménez, Rodrigo
  • Higuero Verdejo, María Isabel
  • González Pastor, Victoria I.
  • Vazirani, Ravi
  • Lanaspa, Arturo
  • Anguita-Gámez, María
  • López Martín, Gonzalo J.
  • Sánchez González, Javier
  • Ibáñez, Borja
Repisalud
Publicación Artículo científico (JournalArticle)

Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21.

  • Pena-Leon, Veronica
  • Folgueira, Cintia
  • Barja-Fernández, Silvia
  • Pérez-Lois, Raquel
  • Da Silva Lima, Natália
  • Martin, Marion
  • Heras, Violeta
  • Martinez-Martinez, Sara
  • Valero, Paola
  • Iglesias, Cristina
  • Duquenne, Mannon
  • Al-Massadi, Omar
  • Beiroa, Daniel
  • Souto, Yara
  • Fidalgo, Miguel
  • Sowmyalakshmi, Rasika
  • Guallar, Diana
  • Cunarro, Juan
  • Castelao, Cecilia
  • Senra, Ana
  • González-Saenz, Patricia
  • Vázquez-Cobela, Rocío
  • Leis, Rosaura
  • Sabio, Guadalupe
  • Mueller-Fielitz, Helge
  • Schwaninger, Markus
  • López, Miguel
  • Tovar, Sulay
  • Casanueva, Felipe F
  • Valjent, Emmanuel
  • Diéguez, Carlos
  • Prevot, Vincent
  • Nogueiras, Rubén
  • Seoane, Luisa M
Early-life determinants are thought to be a major factor in the rapid increase of obesity. However, while maternal nutrition has been extensively studied, the effects of breastfeeding by the infant on the reprogramming of energy balance in childhood and throughout adulthood remain largely unknown. Here we show that delayed weaning in rat pups protects them against diet-induced obesity in adulthood, through enhanced brown adipose tissue thermogenesis and energy expenditure. In-depth metabolic phenotyping in this rat model as well as in transgenic mice reveals that the effects of prolonged suckling are mediated by increased hepatic fibroblast growth factor 21 (FGF21) production and tanycyte-controlled access to the hypothalamus in adulthood. Specifically, FGF21 activates GABA-containing neurons expressing dopamine receptor 2 in the lateral hypothalamic area and zona incerta. Prolonged breastfeeding thus constitutes a protective mechanism against obesity by affecting long-lasting physiological changes in liver-to-hypothalamus communication and hypothalamic metabolic regulation.
Repisalud
Publicación Artículo científico (JournalArticle)

Arterialization requires the timely suppression of cell growth.

  • Luo, Wen
  • Garcia-Gonzalez, Irene
  • Fernández-Chacón, Macarena
  • Casquero-Garcia, Verónica
  • Sanchez-Muñoz, Maria S
  • Mühleder, Severin
  • Garcia-Ortega, Lourdes
  • Andrade, Jorge
  • Potente, Michael
  • Benedito, Rui
The formation of arteries is thought to occur by the induction of a highly conserved arterial genetic programme in a subset of vessels that will later experience an increase in oxygenated blood flow1,2. The initial steps of arterial specification require both the VEGF and Notch signalling pathways3-5. Here, we combine inducible genetic mosaics and transcriptomics to modulate and define the function of these signalling pathways in cell proliferation, arteriovenous differentiation and mobilization. We show that endothelial cells with high levels of VEGF or Notch signalling are intrinsically biased to mobilize and form arteries; however, they are not genetically pre-determined, and can also form veins. Mechanistically, we found that increased levels of VEGF and Notch signalling in pre-arterial capillaries suppresses MYC-dependent metabolic and cell-cycle activities, and promotes the incorporation of endothelial cells into arteries. Mosaic lineage-tracing studies showed that endothelial cells that lack the Notch-RBPJ transcriptional activator complex rarely form arteries; however, these cells regained the ability to form arteries when the function of MYC was suppressed. Thus, the development of arteries does not require the direct induction of a Notch-dependent arterial differentiation programme, but instead depends on the timely suppression of endothelial cell-cycle progression and metabolism, a process that precedes arterial mobilization and complete differentiation.
Repisalud
Publicación Artículo científico (JournalArticle)

Imidazole propionate is a driver and therapeutic target in atherosclerosis.

  • Mastrangelo, Annalaura
  • Robles-Vera, Iñaki
  • Mañanes, Diego
  • Galán, Miguel
  • Femenía-Muiña, Marcos
  • Redondo-Urzainqui, Ana
  • Barrero-Rodríguez, Rafael
  • Papaioannou, Eleftheria
  • Amores-Iniesta, Joaquín
  • Devesa, Ana
  • Lobo-González, Manuel
  • Carreras, Alba
  • Beck, Katharina R
  • Ivarsson, Sophie
  • Gummesson, Anders
  • Georgiopoulos, Georgios
  • Rodrigo-Tapias, Manuel
  • Martínez-Cano, Sarai
  • Fernández-López, Ivan
  • Nuñez, Vanessa
  • Ferrarini, Alessia
  • Inohara, Naohiro
  • Stamatelopoulos, Kimon
  • Benguría, Alberto
  • Cibrian, Danay
  • Sánchez-Madrid, Francisco
  • Alonso-Herranz, Vanesa
  • Dopazo, Ana
  • Barbas, Coral
  • Vázquez, Jesús
  • López, Juan Antonio
  • González-Martín, Alicia
  • Nuñez, Gabriel
  • Stellos, Konstantinos
  • Bergström, Göran
  • Bäckhed, Fredrik
  • Fuster, Valentín
  • Ibañez, Borja
  • Sancho, David
Atherosclerosis is the main underlying cause of cardiovascular diseases. Its prevention is based on the detection and treatment of traditional cardiovascular risk factors. However, individuals at risk for early vascular disease often remain unidentified. Recent research has identified new molecules in the pathophysiology of atherosclerosis, highlighting the need for alternative disease biomarkers and therapeutic targets to improve early diagnosis and therapy efficacy. Here, we observed that imidazole propionate (ImP), produced by microorganisms, is associated with the extent of atherosclerosis in mice and in two independent human cohorts. Furthermore, ImP administration to atherosclerosis-prone mice fed with chow diet was sufficient to induce atherosclerosis without altering the lipid profile, and was linked to activation of both systemic and local innate and adaptive immunity and inflammation. Specifically, we found that ImP caused atherosclerosis through the imidazoline-1 receptor (I1R, also known as nischarin) in myeloid cells. Blocking this ImP-I1R axis inhibited the development of atherosclerosis induced by ImP or high-cholesterol diet in mice. Identification of the strong association of ImP with active atherosclerosis and the contribution of the ImP-I1R axis to disease progression opens new avenues for improving the early diagnosis and personalized therapy of atherosclerosis.
Repisalud
Publicación Reseña (Review)

Defensive-lipid droplets: Cellular organelles designed for antimicrobial immunity.

  • Safi, Rémi
  • Sánchez-Álvarez, Miguel
  • Bosch, Marta
  • Demangel, Caroline
  • Parton, Robert G
  • Pol, Albert
Microbes have developed many strategies to subvert host organisms, which, in turn, evolved several innate immune responses. As major lipid storage organelles of eukaryotes, lipid droplets (LDs) are an attractive source of nutrients for invaders. Intracellular viruses, bacteria, and protozoan parasites induce and physically interact with LDs, and the current view is that they "hijack" LDs to draw on substrates for host colonization. This dogma has been challenged by the recent demonstration that LDs are endowed with a protein-mediated antibiotic activity, which is upregulated in response to danger signals and sepsis. Dependence on host nutrients could be a generic "Achilles' heel" of intracellular pathogens and LDs a suitable chokepoint harnessed by innate immunity to organize a front-line defense. Here, we will provide a brief overview of the state of the conflict and discuss potential mechanisms driving the formation of the 'defensive-LDs' functioning as hubs of innate immunity.
Repisalud
Publicación Artículo científico (JournalArticle)

USP49 deubiquitinase regulates the mitotic spindle checkpoint and prevents aneuploidy.

  • Campos-Iglesias, Diana
  • Fraile, Julia M
  • Bretones, Gabriel
  • Montero, Alejandro A
  • Bonzon-Kulichenko, Elena
  • Vazquez, Jesus
  • López-Otín, Carlos
  • Freije, José M P
The spindle assembly checkpoint (SAC) is an essential mechanism that ensures the accurate chromosome segregation during mitosis, thus preventing genomic instability. Deubiquitinases have emerged as key regulators of the SAC, mainly by determining the fate of proteins during cell cycle progression. Here, we identify USP49 deubiquitinase as a novel regulator of the spindle checkpoint. We show that loss of USP49 in different cancer cell lines impairs proliferation and increases aneuploidy. In addition, USP49-depleted cells overcome the arrest induced by the SAC in the presence of nocodazole. Finally, we report new binding partners of USP49, including ribophorin 1, USP44, and different centrins.
Repisalud
Publicación Artículo científico (JournalArticle)

Embracing cancer complexity: Hallmarks of systemic disease.

  • Swanton, Charles
  • Bernard, Elsa
  • Abbosh, Chris
  • André, Fabrice
  • Auwerx, Johan
  • Balmain, Allan
  • Bar-Sagi, Dafna
  • Bernards, René
  • Bullman, Susan
  • DeGregori, James
  • Elliott, Catherine
  • Erez, Ayelet
  • Evan, Gerard
  • Febbraio, Mark A
  • Hidalgo, Andres
  • Jamal-Hanjani, Mariam
  • Joyce, Johanna A
  • Kaiser, Matthew
  • Lamia, Katja
  • Locasale, Jason W
  • Loi, Sherene
  • Malanchi, Ilaria
  • Merad, Miriam
  • Musgrave, Kathryn
  • Patel, Ketan J
  • Quezada, Sergio
  • Wargo, Jennifer A
  • Weeraratna, Ashani
  • White, Eileen
  • Winkler, Frank
  • Wood, John N
  • Vousden, Karen H
  • Hanahan, Douglas
The last 50 years have witnessed extraordinary developments in understanding mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical framework, our understanding of the molecular basis of systemic manifestations and the underlying causes of cancer-related death remains incomplete. Looking forward, elucidating how tumors interact with distant organs and how multifaceted environmental and physiological parameters impinge on tumors and their hosts will be crucial for advances in preventing and more effectively treating human cancers. In this perspective, we discuss complexities of cancer as a systemic disease, including tumor initiation and promotion, tumor micro- and immune macro-environments, aging, metabolism and obesity, cancer cachexia, circadian rhythms, nervous system interactions, tumor-related thrombosis, and the microbiome. Model systems incorporating human genetic variation will be essential to decipher the mechanistic basis of these phenomena and unravel gene-environment interactions, providing a modern synthesis of molecular oncology that is primed to prevent cancers and improve patient quality of life and cancer outcomes.
Repisalud
Publicación Artículo científico (JournalArticle)

Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.

  • Bernier-Latmani, Jeremiah
  • Cisarovsky, Christophe
  • Mahfoud, Samantha
  • Ragusa, Simone
  • Dupanloup, Isabelle
  • Barras, David
  • Renevey, François
  • Nassiri, Sina
  • Anderle, Pascale
  • Squadrito, Mario Leonardo
  • Siegert, Stefanie
  • Davanture, Suzel
  • González-Loyola, Alejandra
  • Fournier, Nadine
  • Luther, Sanjiv A
  • Benedito, Rui
  • Valet, Philippe
  • Zhou, Bin
  • De Palma, Michele
  • Delorenzi, Mauro
  • Sempoux, Christine
  • Petrova, Tatiana V
Stem and progenitor cells residing in the intestinal crypts drive the majority of colorectal cancers (CRCs), yet vascular contribution to this niche remains largely unexplored. VEGFA is a key driver of physiological and tumor angiogenesis. Accordingly, current anti-angiogenic cancer therapies target the VEGFA pathway. Here we report that in CRC expansion of the stem/progenitor pool in intestinal crypts requires VEGFA-independent growth and remodeling of blood vessels. Epithelial transformation induced expression of the endothelial peptide apelin, directs migration of distant venous endothelial cells towards progenitor niche vessels ensuring optimal perfusion. In the absence of apelin, loss of injury-inducible PROX1+ epithelial progenitors inhibited both incipient and advanced intestinal tumor growth. Our results establish fundamental principles for the reciprocal communication between vasculature and the intestinal progenitor niche and provide a mechanism for resistance to VEGFA-targeting drugs in CRCs.
Repisalud
Publicación Artículo científico (JournalArticle)

Notch-mediated cellular interactions between vascular cells.

  • Cuervo, Henar
  • Mühleder, Severin
  • Garcia-Gonzalez, Irene
  • Benedito, Rui
Vessel formation and differentiation to a proper hierarchical vasculature requires a coordinated effort from endothelial and mural cells. Over the last decade Notch was identified as a key player in this process by promoting vascular arterialization and modulating endothelial tip-stalk phenotypes. Recent work has identified that Notch fine-tunes the diverse endothelial phenotypes through regulation of canonical cell-cycle and metabolism regulators, such as ERK and Myc. During arterialization, Notch signaling inhibits the cell-cycle and metabolism of endothelial cells which coincides with the acquisition of arterial identity. During angiogenesis, the same molecular machinery prevents the hypermitogenic arrest and excessive sprouting of vessels. Notch also signals in pericytes and smooth muscle cells promoting vascular coverage and maturation. Here, we will review the latest findings on how Notch signals regulate the differentiation and interactions among vascular cells during organ development and homeostasis.
Repisalud
Publicación Artículo científico (JournalArticle)

COX7A2L genetic variants determine cardiorespiratory fitness in mice and human.

  • Benegiamo, Giorgia
  • Bou Sleiman, Maroun
  • Wohlwend, Martin
  • Rodríguez-López, Sandra
  • Goeminne, Ludger J E
  • Laurila, Pirkka-Pekka
  • Klevjer, Marie
  • Salonen, Minna K
  • Lahti, Jari
  • Jha, Pooja
  • Cogliati, Sara
  • Enriquez, Jose Antonio
  • Brumpton, Ben M
  • Bye, Anja
  • Eriksson, Johan G
  • Auwerx, Johan
Mitochondrial respiratory complexes form superassembled structures called supercomplexes. COX7A2L is a supercomplex-specific assembly factor in mammals, although its implication for supercomplex formation and cellular metabolism remains controversial. Here we identify a role for COX7A2L for mitochondrial supercomplex formation in humans. By using human cis-expression quantitative trait loci data, we highlight genetic variants in the COX7A2L gene that affect its skeletal muscle expression specifically. The most significant cis-expression quantitative trait locus is a 10-bp insertion in the COX7A2L 3' untranslated region that increases messenger RNA stability and expression. Human myotubes harboring this insertion have more supercomplexes and increased respiration. Notably, increased COX7A2L expression in the muscle is associated with lower body fat and improved cardiorespiratory fitness in humans. Accordingly, specific reconstitution of Cox7a2l expression in C57BL/6J mice leads to higher maximal oxygen consumption, increased lean mass and increased energy expenditure. Furthermore, Cox7a2l expression in mice is induced specifically in the muscle upon exercise. These findings elucidate the genetic basis of mitochondrial supercomplex formation and function in humans and show that COX7A2L plays an important role in cardiorespiratory fitness, which could have broad therapeutic implications in reducing cardiovascular mortality.
Repisalud
Publicación Artículo científico (JournalArticle)

Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.

  • Nikolic, Ivana
  • Ruiz-Garrido, Irene
  • Crespo, María
  • Romero-Becerra, Rafael
  • Leiva-Vega, Luis
  • Mora, Alfonso
  • León, Marta
  • Rodríguez, Elena
  • Leiva, Magdalena
  • Plata-Gómez, Ana Belén
  • Alvarez Flores, Maria Beatriz
  • Torres, Jorge L
  • Hernández-Cosido, Lourdes
  • López, Juan Antonio
  • Vázquez, Jesús
  • Efeyan, Alejo
  • Martin, Pilar
  • Marcos, Miguel
  • Sabio, Guadalupe
Obesity is characterized by low-grade inflammation, energy imbalance and impaired thermogenesis. The role of regulatory T cells (Treg) in inflammation-mediated maladaptive thermogenesis is not well established. Here, we find that the p38 pathway is a key regulator of T cell-mediated adipose tissue (AT) inflammation and browning. Mice with T cells specifically lacking the p38 activators MKK3/6 are protected against diet-induced obesity, leading to an improved metabolic profile, increased browning, and enhanced thermogenesis. We identify IL-35 as a driver of adipocyte thermogenic program through the ATF2/UCP1/FGF21 pathway. IL-35 limits CD8 T cell infiltration and inflammation in AT. Interestingly, we find that IL-35 levels are reduced in visceral fat from obese patients. Mechanistically, we demonstrate that p38 controls the expression of IL-35 in human and mouse Treg cells through mTOR pathway activation. Our findings highlight p38 signaling as a molecular orchestrator of AT T cell accumulation and function.